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Abstract: Iodine deficiency is one of the major causes of preventable brain damage in 
childhood. However, iodine supplementation during early pregnancy and lactation could 
prevent the ill effects of iodine deficiency. In this study we have assessed the effect of 
iodine supplementation to lactating mothers on visual information processing (VIP) of 
their 6-month-old infants in a community-based, randomized, supplementation trial. 
Mother infant dyads (n = 106) were recruited within the first week after delivery to 
participate in this study. Study participants were randomly assigned either to receive 225 
µg of iodine as potassium iodide capsule (capsule group) daily for 26 weeks or iodized 
salt (I-salt group) (450 g) weekly for 26 weeks. Lactating women (n = 53) who had 26 
weeks old infants were recruited to serve as controls. Mother-infant dyads in the two 
supplemented groups were not significantly different in any of the biomarkers and 
anthropometry measurements at baseline. At the end of 26 weeks, maternal thryroxine 
(T4) decreased in the I-salt group (p < 0.001) but remained the same in the capsule group 
(p = 0.45), thyroid stimulating hormone (TSH) and triiodothyronine (T3) significantly 
decreased in both groups but there was no change in thyroglobulin (Tg). Compared to the 
two treatment groups, TSH was significantly lower in the control group. Maternal goiter 
rate significantly decreased following iodine supplementation. Infants median (IQR) T4 at 
26 weeks was 10.8 (8.7, 13.6) µg/dL, 13.9 (10.6, 17.6) µg/dL and 19.6 (16.4, 25.9) µg/dL 
in the capsule, I-salt and control groups respectively. And the difference between the 
three groups was significant (p < 0.001). Compared to baseline, maternal and infant 
urinary iodine concentration (UIC) increased but breast milk iodine concentration 
(BMIC) decreased at the end of the 26 weeks. The percentage of infants who showed 
novelty preference to new stimuli above 0.55 was 26%, 51% and 47% in the capsule, I-
salt and control groups respectively (p = 0.024), but other VIP tests did not show any 
effects of supplementation. In conclusion, iodine supplementation to iodine sufficient or 
mildly iodine deficient mothers did not show significant effects on infant VIP, T4, TSH or 
maternal T4, Tg, UIC and BMIC.
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Iodine is a chemical element found in trace amounts in the human body and is 
primarily obtained through the diet 1. Iodine is essential for the synthesis of thyroid 
hormones, and thyroid hormones regulate the metabolic processes of most cells and play 
important roles in human growth and development 2.  
Iodine deficiency is one of the most common nutritional problems in the world, 
and it is a major public health problem in many parts of the world 3. Due to its multiple 
effects on human health, iodine deficiency is described as iodine deficiency disorders 
(IDDs) 4. Iodine deficiency disorders can cause serious consequences on brain and 
physical development called endemic cretinism 5. In neonates iodine deficiency and 
hence insufficient supply of thyroid hormones to the developing brain could cause 
neonatal goiter, neonatal hypothyroidism, endemic mental retardation, and increased 
susceptibility of the thyroid gland to nuclear radiation 6,7.  
Maternal thyroid dysfunction could be a cause for developmental impairment in 
the offspring.  Severe iodine deficiency during pregnancy causes maternal and fetal 
hypothyroxinemia 8. Mild-to-moderate iodine deficiency could result in poor learning 
ability as well as increased risk of low birth weight, infant morbidity and mortality 9. 
Infants under 2 years of age are one of the most vulnerable groups to be affected by 
iodine deficiency along with pregnant and lactating mothers 10. Globally, it is estimated 
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that 241 million school age children, most of them in developing countries, suffer 
insufficient intake of iodine 11. Moreover, millions of infants born every year are exposed 
to risk of cognitive damage from iodine deficiency 3. However, the degree and types of 
damage produced by mild or moderate maternal iodine deficiency in cognitive and/or 
neurologic function in the offspring is not clear 12.  
In Ethiopia, IDD has been a serious public health problem in all age groups for 
many years. Although data on the situation of IDD in infants are lacking, in school age 
children total goiter rate nationally was nearly 40% in a nationwide survey conducted in 
2005 which indicates the country was severely affected by iodine deficiency 13. In our 
study region (Southern Nations, Nationalities and Peoples Region (SNNPR)), prevalence 
of goiter in school age children was 56.2%, which was the highest rate of any region in 
the country 13. Recently Ethiopia has been identified as one of the few African countries 
where iodine deficiency is still a moderate problem. Despite tremendous progress 
towards eliminating IDD around the world, IDD is reappearing even in developed 
countries 14.  
IDD can be prevented and controlled by providing iodine and iodine can be 
provided in different ways. However, the United Nations Children’s Fund and the World 
Health Organization jointly recommended salt iodization where iodized salt is accessible. 
Iodized salt is a safe, cost effective and sustainable strategy to ensure sufficient intake of 
iodine by all individuals and to improve maternal and infant health 15,16. Globally, over 
70% of households use iodized salt 10. In places where iodized salt is not accessible, for 
pregnant and lactating women a daily dose of 250 µg iodine supplement or a single 
annual dose of 400 mg iodine as an iodized oil supplement is recommended. For children 
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below 2 years of age, a daily dose of 90 µg iodine or a single annual dose of 200 mg 
iodine as iodized oil supplement is recommended 3. However, for infants 0 to 6 months of 
age, because significant amount of iodine is secreted into breast milk, iodine should be 
available through breast milk, provided that the lactating mother is receiving sufficient 
iodine and her child is exclusively breastfed 17.  
According to the Ethiopia Public Health Institute, the national salt iodization 
program was launched in 2012 18. After we collected our data for this study in 2013, it 
was reported that the national iodized salt coverage (above 0 ppm) is 95.2% with 42.7% 
of the households greater than 15 ppm and 23.2% within the national standard (20 to 40 
ppm) 18. However, in our previously conducted study in 2009, in villages in Sidama zone, 
southern Ethiopia, there was not a single household that reported ever consuming iodized 
salt or any kind of iodine supplement 19. Moreover, awareness of iodine deficiency was 
very low, and those who were aware that iodine was important associated its deficiency 
with goiter, but not with an effect on a child’s ability to learn.  
The visual information processing (VIP) paradigm has been used to assess 
infants’ and children’s information processing speed, recognition memory and attention 
in relation to various factors. For instance, infants whose mothers had high blood 
docosahexaenoic acid (DHA) concentration showed fast information processing speed 
over the first year as well as less distractibility in the second year 20. A study conducted in 
Ethiopian infants showed that growth was associated with development of VIP 21. 
  VIP paradigm is a two-phase procedure (habituation to a single stimulus 
followed by a paired-comparison) that measures look duration, novelty preference, and 
shift rate to assess processing speed and memory. An infant’s visual recognition memory 
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is the beginning of cognitive effort which can predict broad cognitive abilities in later 
childhood 21,22. Habituation and recognition memory have been considered better 
predictors of later IQ compared to the standardized tests of developmental level 23. 
Objectives of the study 
The study had two major objectives 
Objective one:  i) to conduct an experimental study on the effect of iodine 
supplementation to lactating mothers on visual information processing (VIP) of their 6-
month-old infants,  ii) to assess efficacy of iodized salt to increase iodine concentrations 
in breast milk and in infants’ urine and to improve mothers and infants thyroid function 
compared  to daily intake of an iodine capsule for six months by lactating mothers, 
Objective two: i ) to assess the effect of the recently launched salt iodization program on 
urinary iodine concentration and rate of goiter in women age 15 to 49 years of age and 
school-age children  and ii) to assess iodine content of household salt and drinking water. 
Hypotheses 
1. Infants 6 months of age from mothers supplemented with iodized salt or iodine 
capsule will perform better in visual information processing measurements than 
infants of the same age from non-supplemented mothers. 
2. Infants 6 months of age from mothers supplemented with iodized salt or iodine 
capsule will have higher urinary iodine concentrations than infants from non-
supplemented mothers. 
3. Lactating mothers supplemented with iodized salt or iodine capsule will have higher 
iodine concentrations in their breast milk and urine, higher concentrations of thyroid 
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hormones, and lower concentrations of thyroid stimulating hormone and 
thyroglobulin in their plasma than non-supplemented lactating mothers.  
4. Iodine content of salt at the household will be significantly lower than the 
requirement.  
Definition of terms 
- Visual information processing: The beginning of cognitive effort that emerges in 
early infancy and is related to processing speed and attention. It can also predict 
broad cognitive abilities in later childhood 22. 
- Cognition: Refers to processes such as attention, language, perception, action, 
association, memory, concept formation, problem solving, and mental imagery 24. 
- Exclusive breast feeding: Infants fed only breast milk and no other liquids or 
solids with the exception of drops or syrups consisting of vitamins, mineral 
supplements or medicines 25. 
- Universal salt iodization: Universal salt iodization is the iodization of all salt in 
the country for human and livestock consumption in order to eliminate IDD 6. 
- Endemic cretinism: Endemic cretinism is characterized by mental retardation, 
severe and irreversible alterations in brain development, and multiple neurological 
signs including deaf mutism, squint, spastic diplegia, motor rigidity, shuffling 
gait, and signs of severe thyroid insufficiency with dwarfism, myxoedma, and 






Significance of the study 
The results from this study will increase understanding of the effects of iodine on 
infant cognition (using visual information processing (VIP) as a measure of cognition). 
Although there is rich body of evidence that maternal IDD ultimately affects infant’s 
cognition, the influence of infant IDD on VIP has not been studied. To the best of my 
knowledge in Ethiopia only one study has reported breast milk iodine concentration with 
limited information and no study has reported about infants’ iodine status. 
One of the best strategies to alleviate iodine deficiency in the community is 
implementing USI. However, because iodine content of salt may decrease due to 
handling, storage and utilization, determining the amount of iodine reaching the 
household was essential. Hence this study assessed household salt iodine level. We 
provided nutrition education to the community regarding the benefits, utilization and 
storage of iodized salt. 
Limitations 
- Because the ethics rule at Oklahoma State University, USA and Hawassa 
University, Ethiopia, do not allow depriving subjects from iodine supplement for 
study purpose, we did not have a control group that began at baseline and 
continued throughout the study.  Instead we recruited mothers who had 6 ± 0.25 
month old infants to serve as controls. 
- The amount of salt that individual women consumed was not quantified.   
- The setup of our VIP test was not ideal (lighting problem, small screen size) 




Organization of the dissertation 
Following the introduction, the dissertation reviewed literature identifying the 
recent prevalence of iodine deficiency in Ethiopia. The importance of iodine to human 
health, particularly its effect on brain function and methods used to evaluate infant 
cognition to date are reviewed.  Availability, accessibility and utilization of iodized salt 
in Ethiopia also are reviewed. This is followed by the research methodology to explain 
the study design, the selection of research participants, and the collection and analysis of 
data. Finally, three separate manuscripts that include the results, discussions, and 





REVIEW OF LITERATURE 
What is iodine? 
Iodine (atomic weight 126.9) is a chemical element found in trace amounts in the 
human body and is primarily obtained through the diet 1. Iodine was first discovered in 
1811 by accident when Courtois was manufacturing gun powder from sea weed. Because 
it has a violet color Gay-Lussac named it iodine, from the Greek for “violet” and 
identified it as a new element. In 1895, iodine was found in the thyroid gland by 
Baumann 26. 
 Iodine is required for the synthesis of thyroid hormones and thyroid hormones act 
by regulating the metabolic pattern of most cells of the organism. Iodine plays a crucial 
part in the process of early growth and development of most organs, especially of the 
brain 2. Iodine, and hence thyroid hormones, are essential for human life 9. A constant 
supply of thyroid hormone is necessary for proper development of the brain and for body 
growth as well as to maintain basal metabolism and functional activity of most organs 27.  
Sources of iodine 
Iodine is widely distributed in the environment as iodide. Iodine found in the soil 
can be washed away by leaching, flooding and erosion, which leaves the soil and 
drinking water depleted of iodine. Plants grown in this soil will be low in iodine content 
and hence humans and animals that rely on these plants will most likely become iodine 
deficient 28. Comparing plants grown in iodine deficient versus iodine sufficient soils, 
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plants grown in iodine-deficient soils might have iodine concentrations as low as 10 
µg/kg, whereas plants grown in iodine-sufficient soils can have approximately 1 mg/kg 
dry weight. Iodine-deficient soils are commonly found in mountainous areas especially 
where there is frequent flooding 9.  
 For people who reside in iodine-deficient areas, the best ways to alleviate iodine 
deficiency are using iodized salt and diversifying local food with foods from iodine-
sufficient areas. Plants and animals that are of marine origin are rich in iodine, because 
they can concentrate iodine from sea water. Iodine containing compounds such as 
fertilizers, livestock feed, and compounds used in irrigation and milk processing can 
increase iodine content in food as well as dairy products 9.   As a study conducted in 
Denmark indicated, the main sources of iodine for the Danish people other than dietary 
supplements were milk and other beverages such as water, tea, coffee, juice, soft drinks, 
beer and wine 29. Major dietary sources of iodine in the United States in addition to 
iodized salt were milk and bread 30. Similarly, in Switzerland, the main sources of iodine 
are bread and dairy products 31. In the early 1920s, Switzerland was the first country to 
fortify salt with iodine in order to control IDDs 32. 
Abuye and Kelbessa 33 in their study in Ethiopian schoolchildren from different 
regions showed that although insufficient amounts of iodine were consumed, the main 
sources of iodine were drinking water and various types of cereals and legumes. The 
amount of iodine consumed from animal products was very small. Additionally in some 
places of the country, cassava consumption could be a cause for increased iodine 
deficiency due to the compound called linamarin which is known to antagonize the 
thyroid gland 34. 
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Absorption and metabolism 
Iodine exists as several chemical forms when it is ingested. It is rapidly and 
almost completely absorbed in the stomach and duodenum in the form of iodide. For 
instance, the iodate used in iodizing salt will be reduced in the gut to iodide before it is 
absorbed 9. The main organs that clear iodine from the circulation are kidney and thyroid 
with fairly constant clearance by the kidney. Clearance by thyroid varies with iodine 
intake. No more than 10% of iodine absorbed is taken up by thyroid in times of adequate 
iodine intake, whereas during chronic iodine deficiency the uptake increases up to 80% 
35-37. Out of the ingested iodine, more than 90% is excreted in the urine, with only a small 
amount in the feces 9. 
 During lactation, the mammary gland secretes iodine into the breast milk after 
concentrating it to provide for the newborn 38. Small amounts of iodine would be taken 
up by salivary glands, gastric mucosa and choroid plexus. Under normal circumstances, 
iodine in the blood is turned over rapidly and has a half-life of approximately 10 hours. 
But this is reduced during iodine deficiency or hypothyroidism and if the thyroid is 
overactive 35-37. 
 Once iodide (I-) is absorbed in the cell, iodide migrates to the apical membrane 
after it is transported into the thyrocyte by the sodium/iodide symporter (NIS) at the basal 
membrane. The enzyme thyroperoxidase (TPO) and hydrogen peroxide (H2O2) oxidize 
iodide and attach it to tyrosyl residues in thyroglobulin (Tg) to produce the hormone 
precursors mono-iodotyrosine (MIT) and di-iodotyrosine (DIT). Then in the follicular 
lumen, residues couple to form thyroxin (T4) and tri-iodothyronine (T3) within the Tg 
molecule. By endocytosis Tg enters the cell and is digested to release T4 and T3 into the 
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circulation, and iodine on MIT and DIT is recycled within the thyrocyte 32. During fetal 
and early postnatal life however, T3 is entirely dependent on its local production from T4 












                Fig 2.1. Iodine pathway in the thyroid cell. Adapted from Zimmermann et al 
2008 32. 
Iodine deficiency 
Iodine deficiency is one of the most common nutritional problems of the world. 
Globally, it is estimated that 2 billion people, most of them in developing countries, 
suffer inadequate intake of iodine 9. The recent data estimated that 241 million (29.8%) 
school age children have insufficient iodine intake 11. Tremendous progress towards 
eliminating iodine deficiency has been done. The number of iodine deficient countries 
decreased from 54 to 32 and the number of iodine sufficient countries increased from 67 
to 105 in the last decade 11. However, iodine deficiency is reappearing even in developed 
countries 14.  
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Due to its multiple effects on human health, iodine deficiency was called as iodine 
deficiency disorder (IDD) 4. IDD refers to the ill effects of iodine deficiency that can be 
prevented through adequate iodine intake 39. The detrimental effects of IDD in all age 
groups have been classified by Hetzel 4 and summarized by WHO 3, as shown in Table 
2.1. 
Table 2.1 The spectrum of iodine deficiency disorders 
Physiological groups Health consequences of iodine deficiency 
All ages Goiter, hypothyroidism and increased susceptibility to nuclear 
radiation 
Fetus Spontaneous abortion, stillbirth, congenital anomalies and 
perinatal mortality 
Neonates Endemic cretinism including mental deficiency with a mixture 
of mutism, spastic diplegia, squint, hypothyroidism, short 
stature and infant mortality 
Children and 
adolescents 
Impaired mental function, delayed physical development and 
iodine-induced hyperthyroidism 
Adults Impaired mental function and iodine-induced hyperthyroidism 
 
The most critical period to be affected by IDD is from the second trimester of 
pregnancy to three years of age 40,41. At these stages normal thyroid hormone 
concentrations are required for optimal development of the brain 3. 
14 
 
The WHO recommended daily intake of iodine is 90 µg/d for children less than 2 
years of age and 250 µg/d for pregnant and lactating women. Iodine intakes more than 
500 µg/d for lactating women and more than 180 µg/d for children do not have added 
health benefit 17.  
 Iodine deficiency occurs when iodine intake falls enough below the 
recommended intake that it fails to meet the needs of the individual and the thyroid gland 
will no longer be able to synthesize sufficient amounts of thyroid hormone. This leads to 
damage of the developing brain and all the aforementioned IDDs 3,4. In children who are 
born and raised in areas with severe iodine deficiency, neurological cretinism could 
occur. Neurological cretinism which has the most marked central nervous system 
damage, leads to neurological abnormalities such as hearing and speech defects, mental 
deficiency and motor defects 42. This damage is related to the mother’s IDD and her 
inability to increase circulating thyroxine during pregnancy 43. 
Iodine deficiency is the main cause of endemic goiter but it also can be caused by 
other goitrogenic substances that interfere with thyroid metabolism. Zimmermann and 
colleagues have compiled the following table on goitrogenic substances and 








Table 2.2 Goitrogens and their mechanism 
 Mechanism 
Foods  
-Cassava, lima beans, 
linseed, sorghum, sweet 
potato 
Contain cyanogenic glucosides; they are metabolized 
to thiocyanates that compete with iodine for thyroidal 
uptake 
-Cruciferous vegetables such 
as cabbage, cauliflower, 
kale, broccoli, turnips, 
rapeseed,  
Contain glucosinolates; metabolites compete with 
iodine for thyroidal uptake 
-Soy, millet Flavonoids impair thyroid peroxidase activity 
Industrial pollutants  
-Perchlorate Competitive inhibitor of the sodium/iodine symporter, 
decreasing iodine transport into the thyroid 
-Others(e.g. disulphides 
from coal processes) 
Competitive inhibitors of the sodium/iodine 
symporter, decreasing iodine transport into the thyroid 
-Smoking An important goitrogen; smoking during 
breastfeeding is associated with reduced iodine 
concentrations in breastmilk; high serum 
concentration of thiocyanate due to smoking might 
compete with iodine for active transport into the 




-Selenium deficiency Accumulated peroxides might damage the thyroid, 
and deiodinase deficiency impairs thyroid hormone 
synthesis 
-Iron deficiency Reduces heme-dependent thyroperoxidase activity in 
the thyroid and might blunt the efficacy of iodine 
prophylaxis 
-Vitamin A deficiency Increases TSH stimulation and goiter through 
decreased vitamin A-mediated suppression of the 
pituitary TSHβ gene 
 
Iodine deficiency in Ethiopia 
In Ethiopia, iodine deficiency has affected a large percentage of the population for 
decades. The Ethiopian Health and Nutrition Research Institute (EHNRI) and UNICEF 
have reported that goiter prevalence in Ethiopia increased from 26% in 1981 to 40% in 
2005. The rate in children was estimated to be 63% in some areas 44. In 2005, Abuye and 
Berhane surveyed goiter status in Ethiopia and found that goiter rate among 15 to 49 
years old women was 35.8%, which included 24.3% palpable and 11.5% visible goiter. 
They estimated that about 6 million women in this age category were affected by goiter. 
In the southern region of the country, out of 1702 women examined for goiter, 43.2% had 
palpable and 17.7% had visible goiter, which is a total goiter rate of 60.9%. These data 
show that Ethiopia, particularly the southern region, is severely affected by iodine 
deficiency 45.  Recently Ethiopia has been identified as one of the few African countries 
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with moderate iodine deficiency 14. Although there are no available data on prevalence of 
cretinism in Ethiopia, it is estimated that in severely iodine deficient areas, cretinism may 
affect 5 to 15% of the population 46. 
Other studies conducted in Sidama zone, near the town of Hawassa, showed the 
severity of iodine deficiency in the area. A study done in Wondo Genet indicated that out 
of 100 women of child bearing age participating in the study, 85% had either palpable or 
visible goiter and 99% had urinary iodine concentration (UIC) below 20 µg/L which is an 
indicator of severe iodine deficiency 47. A cross-sectional study in three kebeles around 
Tula showed that of the 172 pregnant women who participated in a study conducted in 
2010, more than 90% reported they have never heard about iodized salt and 90% never 
consumed iodized salt. Of the 158 pregnant women who were tested for urinary iodine 
concentration (UIC), 157 (99.4%) had UIC below 100 µg/L which indicates iodine 
deficiency 48. A cross-sectional study in three other kebeles (Finchawa, Alamura and 
Tullo) showed that of the 204 women of child bearing age who participated in the study, 
16% had visible or palpable goiter and 97% had UIC below 100 µg/L; the median UIC 
was 37.2 µg/L indicating the presence of moderate iodine deficiency 19. Moreover, a 
study conducted in 7-9 years old school children in Hawassa town indicated that of the 
116 participants who were tested for UIC, 18.9%, 63.2% and 16% had severe, moderate 
and mild iodine deficiency respectively 49.  
Iodine deficiency and brain development 
Iodine is a trace element essential for the synthesis of thyroid hormones, T4 and 
T3 that play a very important role in the process of early growth and development, 
especially the brain. Early human brain development occurs during the fetal and postnatal 
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period 50,51.  Thyroid hormones, through binding of T3 to nuclear receptors, exert action 
to regulate the expression of specific sites in different brain regions following a precise 
developmental process 41. The hormones also play a vital role in the timing, rate and 
quantity of brain cell proliferation by having an effect on RNA polymerase II in 
assembling messenger RNA, and influencing tRNA sulphurtransferase, which causes the 
release of polypeptide chains from ribosomes 52.  This shows the role of iodine and 
thyroid hormones in the growth and differentiation of the central nervous system 53.  
   Iodine is directly involved in cerebral functioning and intelligence.  Cerebral 
development occurs mainly during the fetal period but it continues to develop up until the 
age of 3 years; frontal lobe development may even continue into the third decade. 
Deficiency of iodine or thyroid hormone during this critical period would result in 
slowing metabolic activity of all the cells and also would alter the development of the 
brain which later leads to irreversible mental retardation 54. According to a review, the 
neurological disorders seen as a result of iodine deficiency are mediated by thyroid 
hormone deficiency 55. 
 Iodine deficiency is a preventable cerebral disease 54. People living in areas 
affected by severe iodine deficiency were estimated to have an IQ of as much as 13.5 
points below those of comparable communities in areas where there was no iodine 
deficiency 56. In some regions of India, endemic cretinism in some children even caused 
an IQ deficit of 70 points 57. In a recently published meta-analytical review it was noted 
that populations, specifically children who live in areas where iodine deficiency is 
chronic showed a mean reduction in IQ of 12 – 13.5 points 15. In another systematic 
review and meta-analysis, it was reported that iodine sufficient children age 5 years and 
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younger had IQs that were 6.9 to 10.2 points higher compared to iodine deficient  
children 58. The overall effect of this mental deficiency would have an immediate effect 
on children’s learning capacity, the quality of life in communities, and economic 
productivity 3. 
 In randomized controlled trials, providing iodine supplements to women of 
childbearing age had significant effects on mental development. In Papua, New Guinea, 
an injection of intramuscular iodine before conception eliminated endemic cretinism 5. In 
three other studies, children born to mothers supplemented prior to conception or in 
pregnancy showed better developmental levels compared to children born to non-
supplemented mothers 59-61. Furthermore, children of mothers who had higher thyroxin 
concentrations at 12 weeks of pregnancy had better psychomotor development at 10 
months of age than children of mothers who had lower thyroxin levels 62. In a cohort 
study in Spain, children from iodine sufficient areas showed decreased risk of attention 
deficit and hyperactivity disorders compared to children from iodine deficient areas 63. 
 Although there is not much evidence on the effect of mild iodine deficiency on 
children’s intellectual development, a study in Tuscany showed mildly iodine-deficient 
(64 µg/d) 6 to 10 years old children had a delayed reaction time compared with iodine 
sufficient (142 µg/d) children 41,64. A study in China revealed that mild prenatal iodine 
deficiency could affect infant’s information processing ability and later cognitive 
function. In this study infants with elevated cord blood TSH showed poor performance in 
information processing tasks at seven months of age and poor cognitive development 
index at 13 months of age compared to infants with normal TSH levels 65. 
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In moderately iodine deficient areas, no signs and symptoms of endemic cretinism 
were observed but there were psychoneuromotor and intellectual development 
abnormalities in children. These abnormalities were demonstrated by different tests and 
the results showed that those moderately iodine deficient had low visual-motor 
performance, motor skills and neuromotor abilities, as well as low development quotients 
and IQ 40,66,67. Severe iodine deficiency as mentioned earlier could cause serious 
consequences in physical and brain development which is named endemic cretinism 41,68. 
Iodine needs in pregnancy, lactation and infancy  
Iodine requirement of women is increased during pregnancy and lactation, 
because maternal iodine is essential for the brain development of her offspring during 
fetal and early postnatal life. During pregnancy, the requirement for T4 increases to 
maintain normal metabolism in the mother, the fetus shares T4 and iodide with the mother 
and there is an increased loss of iodide through the kidney 69. Hence, compared to non-
pregnant women, pregnant women have increased recommended dietary intake of iodine. 
The recommended dietary intake for non-pregnant women is 150 µg/d but according to 
the 2001 WHO report, the recommended intake for pregnant and lactating women was 
200 µg/d 39. A later WHO/UNICEF/ICCIDD (2007) report kept the recommended intake 
for non-pregnant women the same, but the recommendation for pregnant and lactating 
women in severely iodine deficient areas was increased to a 250µg daily dose of iodine 
supplement or 400 mg single annual dose of iodized oil supplement and children age 0 – 
6 months should receive iodine through breast milk provided that the child is exclusively 
breastfed 3. According to the Institute of Medicine (IOM) of the US Academy of 
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Sciences, the recommended daily intake for pregnant and lactating women is 220 µg/d 70, 
but others have suggested 175 to 230 µg/d 71,72. 
 Recommended intakes for infants are based on mean iodine intake of healthy full-
term infants fed breast-milk, because functional criteria that reflect iodine intake in 
infants are not available. Hence, based on the IOM, adequate intake for iodine for infants 
age 0-6 months was 110 µg/d. This recommendation was based on two important points. 
First, the median breast milk iodine concentration in the early 1980’s in the United States 
was 146 µg/L. Second, based on the estimated mean daily breast milk excretion, the 
mean amount of iodine obtained by an infant from human milk is approximately 115 
µg/d 70. However, WHO recommends 90 µg/d iodine intake for infants 3. 
 Breast milk iodine concentrations (BMIC) can be increased by high maternal 
iodine intake. In a study in 16 healthy lactating Boston area women BMIC was 
significantly increased after ingestion of 600 µg oral KI 73. However, infants do not 
utilize iodine beyond their requirement. That means any extra iodine is excreted in the 
urine. Therefore, in iodine sufficient countries, the iodine requirement during lactation 
should not be based on the measured amount excreted in breast milk but based on infant 
balance studies 9. Iodine retention of 7.3 µg/kg/d was reported in balance studies of full-
term infants fed 20 µg/kg/d 74. The estimated daily retention of iodine in a six-month-old- 
infant in positive balance is 50 µg if the reference body weight at six months of age is 
seven kg 9,70. 
In a randomized, double blind, placebo-controlled supplementation trial in New 
Zealand, lactating mothers who had been supplemented with 75 µg/d or 150 µg/d of 
iodine for six months had significantly higher iodine concentrations in their breast milk 
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and urine than non-supplemented women. However, the amount of supplementation 
given was not sufficient to raise the mothers’ and infants’ iodine status to an optimal 
level based on the thyroid hormone measurement 75. In studies conducted in lactating 
mothers from Iran and Morocco, BMIC was correlated with UIC (r = 0.44, p < 0.0001) 
and (β = 0.675 – 0.739, p < 0.0001) respectively 76,77. In several other studies, as 
reviewed by Zimmermann iodine supplementation of different doses improved maternal 
UIC, and also thyroid hormones 78.  
As indicated by Abuye and Kelbessa the median iodine content of breast milk in 
Ethiopian women was 5-16 µg/L which shows severe iodine deficiency 33. Other 
countries categorized under severe iodine deficiency were Morocco with 27 µg/L and 
Congo with 15 µg/L 69,79,80. On the contrary, high median iodine concentrations of breast 
milk were found in Korea and Japan, which were 892 and 661 µg/L respectively 69. In 
another study in 50 Korean women considerable elevation of BMIC 198 to 8484 µg/L 
was reported 81. Significant variation of BMIC ranging from 5.4 to 2170 µg/L and from 9 
to 1267 µg/L were also reported 79,82. A study in Boston area lactating women reported a 
median BMIC of 155 µg/L 83. In a double blind, randomized, placebo-controlled study, 
241 lactating women who received 400 mg of iodine as an iodized oil capsule had 
significant increases in median BMIC compared to baseline and to the placebo group 77. 
However, although the sample size was small (only 13 lactating women) and short 
duration (24 hrs), iodized salt maintained better BMIC than single dose, 150 µg iodine, 
supplement daily for three days 84. 
 The epidemiological criteria for assessing iodine nutritional status for pregnant 
women of median urinary iodine concentration classified < 150 µg/L, 150 -249 µg/L, 250 
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- 499 µg/L and ≥ 500 µg/L as insufficient, adequate, above requirement and excessive 
iodine intakes respectively. For lactating women and children < 2 years of age, median 
urinary iodine concentration of 100 µg/l was recommended as adequate iodine intake, but 
no other categories were defined 3. 
Prevention and control of IDD 
Iodine deficiency is a major global public health problem, with consequences that 
are more severe for pregnant, lactating women and infants. Iodine deficiency is one of the 
worst causes of preventable brain damage in childhood. Due to this fact, it is classified as 
a primary problem to be eliminated worldwide 6.   
The best strategy to control IDD is increasing iodine intake through 
supplementation or food fortification. Iodine supplementation can be given using iodized 
oil, which is now recommended in severely endemic areas with no access to iodized salt. 
But iodized salt, compared to iodized oil, is cheaper, has wider coverage, and does not 
require direct contact with each person 6. Food fortification has been done in different 
ways previously. Bread, oil, milk and water have been fortified with iodine to increase 
iodine intake 85-87. However, universal salt iodization was found to be the best strategy to 
meet the goal 6.  
Universal salt iodization (USI) is the iodization of all salt for human and livestock 
consumption in order to eliminate IDD. USI is considered the best solution to iodine 
deficiency for the following reasons. i) salt is consumed by everybody, ii) it can be 
consumed throughout the year, iii) it can be produced by only a few producers which 
makes it easy to control, iv) salt iodization is easy to implement, is cheap ($ 0.4 to 0.5 
cents/kg) and does not affect the color, odor or taste, and v) quality of iodized salt can be 
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easily monitored at different levels such as production, retail and household levels 6. 
However, attention should be given to loss of iodine from salt because iodine in salt 
could be lost easily from improper storage, handling and cooking processes. In a study in 
Wukro town in Northern Ethiopia, it was confirmed that a great amount (57%) of the salt 
iodine content that was available at the production level had been lost when it reached the 
household.  Moreover, it was estimated that 20% of the iodine will be lost during the 
cooking process 3,88. 
The recommendation is to iodize salt at 20 to 40 mg iodine per kg of salt 
(assuming a person consumes 10 g of salt per day) 89. The two forms of iodine used for 
fortification are potassium iodide and potassium iodate. The later is mostly recommended 
in hot and humid climates because it is more stable 89. USI has to be done to this level not 
only to improve urinary iodine but also thyroid function 90. A review in 30 developing 
countries showed that UIC has been positively and significantly correlated with 
household iodized salt availability 91.  
In a prospective study in Denmark four years after a mandatory salt iodization 
program (13 ppm iodine) a lower median thyroid volume was observed in women aged 
18 to 65 years. A larger relative decline of thyroid volume was observed in the younger 
compared to older females from a site where iodine deficiency was moderate 92.  
A 12 year salt iodization program was evaluated in Tanzania (from early 1990’s 
to 2004). School children aged 6 to 18 years were assessed for goiter rate (n = 140,358) 
and UIC (n = 4523). Total goiter rate significantly decreased from 61% in the 1980s 
before USI was implemented to 12.3% in 2004 and the median UIC was found to be 204 
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µg/L. However, some areas of the country were found to have low iodized salt coverage 
and others had excess coverage 93.   
Worldwide, according to the WHO 2004 report, it was estimated that the iodine 
intakes of 36.5% (285 million) of school age children were insufficient. In Africa, it was 
estimated that 50 million children had low iodine intake and 42.6% of the general 
population had insufficient iodine intake (UI < 100 µg/L). Among the WHO regions in 
the world, iodine intake was insufficient in 54 countries and hence USI needs to be 
strengthened or implemented 6. In 2007, it was reported that over 30 countries had 
achieved USI, which means more than 90% of households in those countries consumed 
iodized salt.  In 2001 in Africa, the percentage of households having access to iodized 
salt was 63% 3. 
By 2010 in Ethiopia, despite the serious iodine deficiency troubling the country, 
no iodization program had been implemented except the 1988 salt iodization program in 
Port Assab which is now separated from the country due to the dispute with Eritrea. This 
shows that minimal attention has been given to the importance of iodized salt. The 
average salt consumption in the country was estimated to be 8.4 ± 5.9 g per person per 
day.  Only 4.2% of households reported consumption of iodized salt during the national 
survey in 2005, and in SNNPR, only 2.2% used iodized salt 13. Moreover, among the 
10,998 women respondents who participated in one study, 93% said they did not know 
the importance of iodized salt and 91% said they did not know the cause of goiter. In 
SNNPR, the percentages were 98.5 % and 95.7 % respectively. Legislation was initiated 
to implement USI, which includes prohibition of production, importation and distribution 
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of non-iodized salt in the country and this legislation was signed in 2011 and USI has 
been implemented since 2012 18,45. 
 In 2011 it was reported that out of 94% of households who had salt tested for the 
presence of iodine, only 15% of households in Ethiopia and 12.2% of households in 
SNNPR were using iodized salt. Among these, 23% were urban households and 13% 
were rural households 94. Criteria set by WHO for monitoring progress towards 
sustainable elimination of IDD as a public health problem are presented in the following 
table 39. 
Table 2. 3. Criteria for monitoring progress towards sustainable elimination of IDD 
Indicators Goals 
Salt iodization coverage  
Proportion of households consuming adequately iodized salt > 90% 
Urinary iodine  
√ Proportion of population with UI level below 100 µg/L < 50% 
√ Proportion of population with UI level below 50 µg/L < 20% 
Programmatic indicators At least 8 of 
the 10 
√National body responsible to the government for IDD elimination. It 
should be multidisciplinary, involving the different fields of nutrition, 
medicine, education, the salt industry, the media, and consumers, with the 
chairman appointed by the Minister of Health 
 
√ Evidence of political commitment to USI and elimination of IDD  
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√ Appointment of a responsible executive officer for the IDD elimination 
program 
 
√ Legislation or regulation of USI  
√ Commitment to regular progress in IDD elimination, with access to 
laboratories able to provide accurate data on salt and UI 
 
√ A program of public education and social mobilization on the 
importance of IDD and the consumption of iodized salt 
 
√ Regular data on iodized salt at the factory, retail and household levels  
√ Regular laboratory data on urinary iodine in school age children, with 
appropriate sampling for higher-risk areas 
 
√ Co-operation from the salt industry in maintenance of quality control  
√ A database for recording results or regular  monitoring procedures 
particularly for  iodine, urinary iodine and , if available, neonatal thyroid 
stimulating hormone (TSH), with mandatory public  reporting 
 
 
Side effects of iodine supplement and contraindications   
Some populations, such as in some parts of Japan, who depend on sea foods for 
their daily food may consume as much as are 50,000 to 80,000 µg or 50 to 80 mg of 
iodine per day 95, although the safe upper limit for iodine supplement has been set at 1000 
µg/d 70. When taken according to the recommendations, iodine is known to be safe. 
However, some individuals might be hypersensitive to supplements even at the 
recommended dose. Hence, individuals who have pre-existing autoimmune thyroid 
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pathologies should be excluded from participating in studies that include iodine 
supplement 96.  
Iodine and other nutrient interactions 
Multiple micronutrients including selenium, iron and vitamin A are involved in 
iodine and thyroid metabolism. In areas of endemic goiter it is important to consider 
micronutrients which directly or indirectly affect the problem 97. 
As reviewed by Zimmermann 98, in another study the effects of combined vitamin 
A and iodine deficiency on the thyroid axis of rats was studied. Accordingly, it was 
observed that compared to the control groups (rats that were vitamin A and iodine 
sufficient) the vitamin A and iodine deficient (ID) rats had increased serum TSH, TSHβ 
mRNA, and thyroid weight and had decreased FT4 and TT4. This study also confirmed 
that concurrent vitamin A deficiency (VAD) and ID were more likely to cause primary 
hypothyroidism compared to ID alone and had more effect on the pituitary thyroid axis 
compared to VAD alone 99. Abnormality of the pituitary-thyroid axis caused by ID and 
VAD was reversed by supplementation with an iodine rich diet. Thyroid size and 
hyperstimulation were also reduced by vitamin A supplementation, and this was assumed 
the result of effect of vitamin A on pituitary TSHβ gene expression 100. 
In an animal study comparing iron sufficient rats with deficient rats, decreased 
plasma triiodthronine (T3) and thyroxin (T4) concentrations were found in iron deficient 
anemic (IDA) rats 101. Reduced TSH response to lower circulating T3 and T4 
concentrations was observed in rats with severe IDA. On the contrary, iron-sufficient 
animals showed significantly higher T3 turnover and elimination than iron- deficient 
animals. Moreover, anemic rats had decreased hepatic selenium-dependent 5’ deiodinase 
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activity which is involved in the conversion and activation of the inactive thyroid 
hormone (T4) to its active form (T3) 102. The impairment of 5’deiodinase activity was 
greater in severe IDA compared to mild IDA rats 103. 
In human studies, adults who had severe goiter had increased retinol binding 
protein, serum retinol and transthyretin (TTR) concentrations. Furthermore, in children 
who were affected by severe IDD, TSH stimulation and thyroid size were increased and 
risk of hypothyroidism was decreased 98. Significant decreases in serum retinol and 
retinol binding protein (RBP) were observed in Ethiopian children with visible goiter 
compared to children without goiter 104. In an efficacy study, 6 to 14 years old Moroccan 
children were given 25 µg/g of iodized salt (IS) and were divided into two groups. The 
first group (IS group) received an oral placebo (sunflower oil) at 0 and 5 months, while 
the second group (IS + VA group) received an oral VA supplement (200,000 IU as retinyl 
palmitate) at 0 and 5 months. At 10 months, mean serum retinol, RBP, and RBP/TTR 
ratio increased significantly, median TSH and Tg levels decreased significantly and mean 
goiter volume and rate decreased significantly in the IS + VA group compared to the IS 
group. A significant reduction was also observed in the number of children with VAD in 
the IS + VA group 105.  
Studies suggested that reduced activity of thyroid peroxidase (TPO), the iron-
dependent enzyme in IDA, could be the reason for impaired thyroid hormone 
metabolism. In a study with iron sufficient and deficient diets, rats that received an iron 
deficient diet had decreased circulating T3, T4 and Hb concentrations, and TPO activity 
was also decreased compared with the control animals 106. In humans, anemic women 
showed reduced T3 and T4 concentrations compared with healthy women but not 
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significant differences in TSH concentration 107. In an intervention study in Côte d’Ivoire, 
goitrous children 6 to 12 years old were assigned into two groups. Children in group 1 
were goitrous but without anemia and group 2 consisted of goitrous children with anemia. 
All children in both groups received iodized poppy seed oil containing 200 mg of iodine 
as a capsule. Thyroid volume and goiter rate were significantly reduced in group 1 at 15 
and 30 weeks after intervention compared to group 2. Compared with baseline value, 
group 1 children had significantly reduced median TSH values at 15, 30 and 50 weeks. 
When both groups were combined, median TSH was significantly reduced and T4 value 
was significantly increased in group 1 at 15 and 30 weeks 108,109. 
Iron supplementation (60 mg Fe/d, 4 d/wk for 4 months) to iodized salt 
supplemented goitrous children in Côte d’Ivoire significantly decreased mean thyroid 
size twice as much as in the placebo group. A goiter rate of 43% or 62% was observed in 
the iron supplemented and the placebo group respectively (p < 0.02) 110. In an area of 
borderline iodine deficiency, poor maternal iron status was found to predict lower and 
higher TSH concentrations in pregnant women 111. In a randomized, double blind, 
controlled trial, children 6 to 15 years old were supplemented either with iodized salt (25 
µg iodine/g salt) or with salt fortified with iodine (25 µg iodine/g salt) and iron (1g Fe/g 
salt). For several indicators children in the dual-fortified group showed better 
improvement compared to the control group. For instance, mean thyroid volume, 
prevalence of goiter and hypothyroidism were significantly decreased and serum 
thyroxine was significantly increased 112. 
Selenium (Se) is one of the trace minerals involved in the synthesis and 
metabolism of thyroid hormone. The role of Se in organification, radioiodide uptake and 
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thyroid hormone synthesis has been observed in animal models. An inadequate Se supply 
decreased glutathione peroxidase (GPx) activity in the thyroid. Moreover, Se deficiency 
in animal models decreased renal and hepatic type I 5’-deiodinase and brain type II 5’ 
deiodinase that play important roles in thyroid hormone metabolism 97. In iodine-
supplemented goitrous children, the positive effect of iodine on thyroid volume and 
serum TSH was inhibited by Se deficiency 108. Selenium supplement (100µg sodium 
selenite daily for three months) also improved the T3/T4 ratio 113. 
Cognition 
Cognition refers to processes such as attention, language, perception, action, 
association, memory, concept formation, problem solving, and mental imagery 24. 
Cognitive function refers to the processing of information taken in from the environment 
and reflected in the form of behavior 114. 
Cognition includes visual and somatosensory perception, thinking, memory and 
learning and is considered to be an outcome of millions of metabolic processes where its 
main task is registering, encoding, selecting, maintaining, transforming, storing and 
retrieving information 115. Cognition, as well as its elements that include reasoning, 
attention, memory, and psychomotor coordination, is complex. Memory for instance, a 
part of cognition, includes visual, long term, short term, verbal, spatial, declarative, 
strategic, and semantic aspects and requires several tools for assessment 116. As another 
example, attention is widely considered to be a single unit involving several separable 
systems that are mediated by their own pathways 117.  
      Cognitive function, as defined by Wainwright and Colombo (2006), is the neural 
process that is necessary to support the flexible use of information to carry out adaptive 
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and goal-directed behavior. The ability to execute adaptive behavioral responses depends 
on the capacity to focus and maintain attention and these processes also depend on the 
holding capacity of information in working memory 118. Other information processing 
functions that are known to be more complex are also involved. One example could be 
the ability to use conceptual information and organize it in a meaningful way for 
appropriate responses in different contexts and to hold back other competing behavioral 
responses 118. 
Brain and cognitive function 
The decision-making processes and information processing of the mammalian 
brain are mediated by neural circuits comprising a series of reciprocal cortical-subcortical 
loops. The cortex is the place from which these circuits originate and then project to 
various sub-cortical structures including basal ganglia and nucleus accumbens. Circuits 
then return to the region of the cortex, via the thalamus 119. These structures and 
pathways are influenced by the inputs from many other regions of the brain and the 
presence of such functional interactions between these structures is essential to both 
behavioral and physiologic regulation 120,121. The hippocampus, an important source of 
input to the nucleus accumbens, in addition to the prefrontal cortex, is necessary for the 
formation of long-term memory 120,122. The hippocampus, by representing the relations 
between distinct stimuli, also plays a role in higher-level decision-making processes 122. 
The hippocampus is also involved in novelty preference 123. 
The prefrontal cortex, during the decision making process, generates possible 
behavioral alternatives in response to the specific nature and emotional categorization of 
sensory stimuli which can later be transferred to the nucleus accumbens 124. Neural 
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transmission involving the hippocampus, prefrontal cortex, and nucleus accumbens is 
vital in enabling behavioral flexibility 125. 
      The amygdala, another source of input to the nucleus accumbens is involved in 
processing the affective emotion of sensory stimuli and passing on this information to the 
prefrontal cortex 120,126. In addition, the amygdala also plays a vital role in stress 
responses during occurrence of perceived dangers 126. According to McGaugh, the stress 
response includes the release of glucocorticoid hormones 127. Appropriate concentrations 
of glucocorticoids are necessary for mnemonic functions to be accomplished effectively 
and the hippocampus together with the prefrontal cortex, are involved in the feedback 
regulation of these glucocorticoid concentrations 128. 
Infant’s visual recognition memory 
Infant’s visual recognition memory is the beginning of cognitive function which 
can predict broad cognitive abilities in later childhood 129. Follow up data by Fagan and 
McGrath have shown the relation between infant visual recognition memory and later 
cognition 130. Children tested for visual recognition memory at the age of 4 and 7 months 
were tested again for their performance on the Peabody Picture Vocabulary Tests and/or 
other vocabulary scales at the age of 4 and 7 years and a positive correlation was 
observed between the two tests. Predictive relations between infancy and 3-year IQ were 
found using the Fagan Test of Infant Intelligence 131,132. 
 The defining feature of infant visual recognition memory is the responsiveness to 
novelty, which is central to biological adaptation and to other cognitive development 
theories and intelligence. Infant visual recognition memory explains that previous 
knowledge can be inhibited by new events through the process of accommodation, and 
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the ability to deal with the new knowledge or events plays a major role in the human 
experimental theory of intelligence 133,134. There exist individual differences in visual 
recognition memory and infant recognition memory show significant correlation with 
several cognitive abilities in later childhood 134. Rose and colleagues (2004) also 
documented that visual recognition memory is affected by several factors that affect adult 
memory which include forgetting, speed of processing and attention 22. 
In a study on chimpanzees by Fantz (1964) the chimps showed preference for 
novelty. He presented a photo for one minute, 10 times in succession, and each time he 
presented the photo paired with a new one. He observed that infant chimpanzees over two 
months of age showed an increasing attention to the novel picture and decreasing 
attention to the familiar pattern. The finding gave a strong base to the visual paired-
comparison task, and hence to the study of visual recognition memory in infancy 135. In 
recognition memory, the first measure is a ‘novelty score’ which is the percentage of 
looking during the test directed to the novel target 136,137. The theory is that when infants 
come across a new stimulus, they try to match it with the stored information in their 
mind. If it is similar, their attention deviates. If it is not, attention remains engaged until 
enough information about the new stimulus is obtained and familiarized 138.  
The principle of visual information processing is also explained by the theory of 
habituation and dishabituation. According to Sokolov (1963), when infants are presented 
continuously with the same stimulus their attention decreases, which is a result of the 
gradual construction of a memory trace of the visual stimulus. This phenomenon is called 
visual habituation. Short looking times show fast habituation and relatively longer 
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looking times show slow habituation138. This paradigm uses mean infant look duration as 
the dependent measure 139. 
On the other hand, following habituation, attention diverts to a new stimulus 
encountered and this attention diversion is referred to as dishabituation. Hence, 
comparing the looking time towards the habituation stimulus at the end of the habituation 
phase with looking time towards the novel stimulus will indicate the strength of 
dishabituation. Both visual habituation and dishabituation would indicate basic 
information-processing skills. In a meta-analytical review, it was reported that it is 
possible to predict later childhood IQ from infant’s habituation-dishabituation 
performance 140. However, although habituation was related to later cognitive and 
language outcomes this relationship was recently criticized because it is unlikely that 
habituation can be considered as a primary component of intelligence but rather a starting 
effort of learning and cognition upon which higher level functions can be built later in 
childhood 139. Habituation was also described as cognitive encoding and dishabituation 
was referred to as discrimination and memory 141. Kavesk (2004) pointed out that 
dishabituation is sensitive in predicting later intelligence in at risk groups whereas in non-
risk groups habituation is better 140. 
Among the factors that influence immediate recognition, familiarization time (the 
time needed to encode what is seen) is most important. Familiarization time is affected by 
age; that is, older infants need a shorter time to become familiar with the stimulus 
compared with younger infants 22.  A study conducted by Rose (1983) measured 
familiarization time differences in infants age 6 and 12 months old. The test was to 
recognize three dimensional geometric figures at 10, 15, 20 and 30 seconds 
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familiarization. The 12 month old infants showed significant novelty scores at all 
familiarization times whereas the 6 month olds showed only at 20 and 30 seconds 
familiarization times. Hence, the ability to recognize at 10 and 15 seconds indicates those 
older infants recognized the stimuli faster than the young ones 142.  
Other studies have demonstrated that infants can recognize delayed stimuli. In a 
study by Fagan (1973), infants aged 4 to 5 months were able to recognize abstract 
patterns after 2 days delay 143. In another experiment, they were able to recognize a 
photograph of a man or a woman after 2 weeks delay. However, the familiarization time 
and pattern determined the recognition. For instance, infants recognized more when the 
practice or familiarization periods were distributed over relatively longer times than 
shorter times 22. 
When familiarization times were relatively short, retention increased over the first 
year of life. Infants aged 5 to 6 months were able to recognize faces after 2 minutes delay 
following 10 seconds familiarization but infants aged 4 months could not 144. Consistent 
with this, Rose (1981) found that 9 month old infants recognized patterns and faces 
immediately after 5 and 20 seconds and also after 2 to 3 months delay but 6 month olds 
only recognized the patterns and faces when displayed immediately 145. Speed of 
processing is a very important variable because faster processing speed is related to better 
cognitive performance 20.  
 In general, as mentioned earlier, infants’ visual recognition memory shows a true 
cognitive ability that is confirmed in later age in predicting broad cognitive abilities such 
as IQ and language. These predictive relations were similar for preterm and full-term 
infants and the results were consistent after controlling several confounding factors such 
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as maternal education, socio-economic status, medical risk and others. This indicates that 
the basis of cognition later in childhood can be found in infancy 22.  
Factors affecting visual recognition memory 
Factors that affect childhood cognition were found to affect infant visual 
recognition memory as well. Factors include prematurity, perinatal circumstances such as 
long labor, genetic abnormalities such as Down’s Syndrome, prenatal exposure to drugs, 
nutritional deficiency, breast feeding, maternal education and others 65,146-151. Preterm 
infants (average birth weight of 1.9 kg) and full-term infants at 4 months have been 
compared on four problems. The mean novelty score in the preterms was significantly 
lower than for full terms and also full terms showed recognition memory unlike preterms 
152. The memory deficit in preterms also showed in 12 month old infants 153. Similarly, in 
another study, preterm and full term infants were tested with faces and abstract designs 
and full terms showed significantly better novelty recognition compared with preterms 
154. Differences within full-terms were also shown due to perinatal complications. Caron 
and colleagues (1983) found poor recognition memory in full-term infants who 
experienced different birth complications such as abnormally long labor, being small for 
gestational age, and low APGAR scores 147. Moreover, preterm infants showed poor 
recall memory at one year of age that could persist into early childhood 153. 
In a cross-sectional study, 100 healthy full term infants were divided into five 
different age groups including 14 weeks, 20 weeks, 26 weeks, 39 weeks, and 52 weeks. A 
series of eight different stimuli were shown to these infants to examine the process of 
look duration as a function of age and type of stimulus. Consistent with other studies the 
look duration decreased from 14 to 26 weeks for all stimuli types but after 26 weeks the 
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course of look duration deviated according to stimulus type. For instance, 6-month-old-
infants showed more looking and increased heart rate to more complex stimuli than to 
simpler ones 155. In a meta-analytical review, it was noted that in the first month of life, 
look duration increases followed by decreases at the age of 6 to 9 months 141.  
A study in India on 5 to 12 month old infants showed nutritional status assessed 
by anthropometric measurements made a difference in visual recognition memory. 
Underweight infants showed poorer visual recognition memory and also failed to show 
age-related improvements observed in normal infants even after controlling for previous 
illness, birth weight, and parental education 150. Kennedy and colleagues reported that 
development of visual information processing (VIP) in 6 to 8 month old infants was 
associated with growth. Moreover, they demonstrated that VIP can indicate infant 
cognitive development and it was also sensitive to nutritional factors 21.  
Nutrition and cognition 
Nutrition is one of the major factors affecting cognition 116. Due to the fact that 
about 70% of the major development of the brain takes place during the prenatal period 
and most of the remaining 30% is during the first three years postpartum, optimal 
nutrition is most fundamental during pregnancy and the first 3 years of life 156.  
Diet affects neurochemistry in two ways.  First, neurotransmitters are synthesized 
by enzymes which require co-factors such as minerals and vitamins obtained from food. 
Second, neuronal functions are influenced by the composition of myelin sheath and cell 
membranes which are also affected by diet 157. 
Cognition is influenced by various environmental factors at different stages of 
life; however, the effect of nutrition is thought to be crucial throughout life. The role of 
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nutrition on cognition is getting attention because it is now realized that the development 
of the brain occurs at more stages of the lifespan than previously understood 158. Nutrition 
is one of the major environmental variables that can be manipulated relatively easily with 
regard to brain function. Not only does nutrition affect brain development but it also 
plays a significant role in maintaining the function of the brain 114. 
A study conducted in Guatemala showed that slower reaction time on 
neuropsychological tests such as perception, attention, memory and reasoning was 
observed in vitamin B12 deficient school-aged children than those who were not deficient 
159. Several studies suggest that micronutrient deficiencies such as iron, zinc, vitamin A, 
and iodine bring about impairments in growth, immune competence and cognitive 
function among children 160,161. Such adverse health consequences can lead to a reduction 
in both reproductive and intellectual potential in adulthood 162.  All domains of cognitive 
functioning were impaired by micronutrient deficiencies and were sensitive to change 
due to micronutrient status among children 163,164,41.  
DHA and visual habituation 
In a randomized, double blind, controlled study two groups of pregnant women 
were supplemented during the last trimester of the pregnancy with either eggs that 
contained 135 mg docosahexaenoic acid (DHA) per egg or ordinary eggs that contained 
35 mg DHA per egg. The objective of the study was to evaluate the effect of maternal 
DHA on development of attention in their infants and toddlers. Colombo and colleagues 
found that infants of mothers consuming high DHA showed increased developmental 
attention and shorter look duration on the habituation stimuli that were pictures of 
children’s faces. Thus they had decreased look duration indicating DHA affects attention 
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positively. Similarly, toddlers of mothers with high levels of DHA showed better 
developmental profiles on single-object measures and more optimal performance on 
distractibility assessments unlike the others 20. Shorter looking time on stimuli during 
infancy has been associated with greater cognitive functioning later in childhood 140. 
Summary 
In conclusion, visual information processing as a measure of cognitive 
functioning is influenced by several nutritional and non-nutritional factors. Among the 
nutritional factors, iodine is one of the few nutrients that is well established to affect the 
brain, but its effect on visual information processing of infants is unknown. Several trials 
have shown cognitive disability as a result of iodine deficiency can be reversed by iodine 
supplementation. Its effect should be highly beneficial when implemented at an early 
stage. In a population where iodine deficiency is prevalent, iodized salt supplementation 
is found to be one of the best stable and safe interventions to alleviate iodine deficiency 







Data source and the study population 
Participants for this study were selected from women and their infants living in 
rural areas of Sidama zone, southern Ethiopia. The study population depends on 
subsistence farming for their livelihood. Their major staple food is enset (Enset 
ventricosum) followed by unrefined maize 165. The area is known for multiple 
micronutrient deficiencies and iodine deficiency is one of the major prevalent problems. 
In selecting the site three important factors were considered. First, from our 
previously conducted research, we knew that the area is severely affected with iodine 
deficiency. Second, none of the study population had ever consumed iodized salt at the 
time of last study and hence, the effect of iodized salt would easily be seen. Third, due to 
the fact that we have done repeated research in the area and because Hawassa University 
has a strong link with the community, conducting intervention research is useful in order 
to plan for sustainable projects for the benefit of the community. 
Objective one 
Subject selection methodology  
A total sample size of 159 subjects was calculated using an alpha of 0.05, 80% 
power and an effect size of 0.25. Of these 159 women and their infants, 53 women were 
to be selected to serve as controls and 106 were to be assigned to serve as treatment 
groups (53 in iodine capsule and 53 in iodized salt groups). Prior to data collection ethical 
clearance was obtained from Oklahoma State University, USA, the Ministry of Science 
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and Technology and the Food, Medicine, and Health Care Administration and Control 
Authority of Ethiopia. Following receipt of ethical clearance, study participants were 
selected with the help of health extension workers in the study area.  
For selecting participants two important criteria were established. First, the 
women must have been lactating and must have infants of specific ages:  a) less than or 
equal to one week old infants for the treatment groups, or b) 6 ± 0.25 month old infants 
for the control group.  Second, mothers had to volunteer to participate in the study. Based 
on these criteria, participants were given a detailed explanation about the objectives of 
the research and consent was taken from the women for themselves and their infants 
before data collection was started.  
Exclusion criteria 
The exclusion criteria in this study were if mothers had any hyperthyroidism 
symptoms manifested by nervousness, anxiety, heart palpitations, rapid pulse, 
fatigability, tremor, muscle weakness, weight loss with increased appetite, heat 
intolerance, frequent bowel movements, or increased perspiration 166. If infants had fever, 
cough or severe (>3/day) diarrhea, they would not be enrolled in the study. If mothers 
showed any allergic reaction such as acne, weakness or foul breath after supplementation 
started they would be excluded from the study as well. However, no one showed or 
reported any of the symptoms. 
The research team (the PI and data collectors) first met with leaders and 
community health workers from the Kifle-Ketema (A small administrative unit which 
contains 12 kebeles) and explained the objectives of the research and procedures for data 
collection at baseline. With the help of community health workers, all mothers within one 
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week after delivery in each of the eight selected kebeles and their infants were invited to 
participate and study enrollment was continued until the required sample size was 
attained.  These mothers were given iodized salt or iodine capsule based on the random 
assignment and served as the treatment groups. Subsequently, all women with 6 ± 0.25 
month-old infants were recruited to serve as control. Once the required data were 
collected the mothers in the control group were provided with iodized salt for six months.   
Research design 
A community-based, randomized, controlled trial was used in this study. The 
study employed an experimental design in order to test hypotheses to establish cause-
effect. The experimental groups were the groups manipulated by the researcher by giving 
different treatments; in this case, those lactating women and their infants who received 
iodized salt or iodine capsule supplement for 6 months beginning at the birth of the 
infant. The control group was composed of lactating women and their 6-month-old 
infants who were tested for VIP and provided all required data at baseline. The study was 
longitudinal in nature due to the fact that iodine status of lactating women and infants in 
the treatment groups were measured twice.  
Eight kebeles were selected. At baseline, control groups were established by 
recruiting mothers of 53 six month old infants from all of the eight kebeles. Mother-child 
dyads were registered and VIP was tested in infants. The mothers then were given 
iodized salt supplements for themselves and their families for six months. For the 
experimental groups, 106 women and their infants from all of the eight kebeles were 
recruited for the study within one week of delivery. These mother-child dyads were 
randomly assigned to iodine capsule (n = 53) or iodized salt (n = 53) groups. The iodine 
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capsule group received 225 µg of iodine daily as a capsule of potassium iodide (Capsules 
were prepared for this study purpose by Pure Encapsulations, Inc. Boston, MA) daily for 
6 months. Supplementation started within one week of delivery. Capsules were delivered 
to the mothers every day by the health extension workers. The experimenter supervised 
the mothers taking the capsules once a week. The iodized salt group was provided with 
iodized salt as 30 to 40 µg/kg of KIO3 (1 packet (450 g) of salt per week per household) 
for 26 weeks) for themselves and their family’s use starting within one week of delivery 
until 6 months. After 6 months, VIP was tested on the 106 infants whose mothers 
received supplemental iodine as iodine capsule or as iodized salt. These results were 








Training was given to data collectors on the questionnaire, anthropometric 
measurements, VIP measurement and urine sample collection technique prior to data 
collection. The questionnaire and anthropometric measurements were pretested on 10 
women and 10 infants who were not included in the study and the VIP test was also 
pretested in the same infants. 
Data collection took place in eight kebeles, and data collectors including the PI 
went to the kebeles three times a week to collect the required data as infants reached the 
appropriate ages. For the control group, mothers with their six months old children were 
invited to come to the community health post. For the treatment groups, data collectors 
and the PI went home to home to collect the baseline data from mothers and their infants. 
When the infants reached six months of age, mothers and their infants were invited to 
come to the community health post for end point data and VIP test for the infants.  Data 
were collected according to the following procedures. See also Table 3.1. 
o Questionnaire  
Due to the nature of the study it was important to assess several variables that 
were thought to affect the problem of interest. Hence, several instruments were used to 
measure the intended variables.  
The questionnaire included three major sections. The first section asked about the 
socioeconomic status and demographic characteristics of women using a standardized 
questionnaire adopted from the Ethiopian Demographic and Health Survey Agency 167. 
The second section included household food insecurity 168,169 and hunger 170.  And, the 
third section included questions about knowledge of the importance of iodine, barriers to 
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iodized salt procurement, and breastfeeding, complementary feeding and related 
practices. Data collectors read questions to mothers. 
- Anthropometric measurement 
o Materials 
As a measure of women’s nutritional status, weight and height were measured to 
calculate body mass index (BMI = Wt (kg)/Ht2 (m). Mid upper arm circumference 
(MUAC) was also measured. As indicators of the infant’s nutritional status, head 
circumference, MUAC, weight and length were measured. Infant’s weight-for-age, 
length-for-age, weight-for-length, MUAC and head circumference were converted to Z-
scores using WHO Anthro software (Version 2.0.4).  
o Procedure 
Each woman’s weight was measured on a solar digital scale (Uniscale, UNICEF, 
NY) and recorded to the nearest 100 grams. Women wore light clothing and removed 
shoes and heavy outer wear (e.g. sweaters) before obtaining weight. Height was 
measured to the nearest 0.1 cm using a single calibrated instrument (Adult Board, Shorr 
Productions, Olney, MD). Participants stood bare footed on a flat surface with weight 
distributed evenly on both feet, heels together, and the head positioned so that the line of 
vision was perpendicular to the body. Arms were hanging freely by the sides, and head 
back. Buttocks and heels were in contact with the vertical board. Mid upper arm 
circumference was measured using a plastic measuring tape. Anthropometric 
measurement instructions were adopted from Gibson 171. All measurements were taken in 
duplicate and averages were taken for analyses.  
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Infant weight was measured using a Seca 345 infant scale and recorded to the 
nearest 2 grams. Infants wore light t-shirts of known weight and laid down on the scale. 
Their actual weight was calculated by subtracting the t-shirt weight from the total weight. 
The recumbent length was measured using a length-board (Shorr Productions, Olney, 
MD) and recorded to the nearest 0.1 cm. The head circumference and mid upper arm 
circumference were measured using a non-stretchable plastic tape and recorded to the 
nearest 0.1 cm. All measurements were taken in duplicate and averages were taken for 
analyses.  
Visual information processing (VIP) administration 
o Materials 
For visual information processing measures, eight pictures of young adult 
Ethiopian faces without emotional expression (four males and four females) were used. 
Two laptop computers were used. One computer was used to control the presentation of 
stimuli. A second computer that has a built-in camera was used to follow and record the 
infant’s looking behavior. Although the infant’s looking behavior was coded live, the 
infant’s looking process was recorded on this second computer for later reliability testing.  
o  Procedure 
A quiet room was prepared for the data collection process. The infant sat on 
mother’s lap in front of the camera, eyes forward, and half a meter away from the screen. 
A bed sheet was placed between the VIP tester and the infant and hence the researcher 
was out of sight of the infant. The tester adjusted the visibility and focus on the infant’s 
face and eyes through a camera built in on the laptop. Once the focus was adjusted, the 
familiarization phase began. A randomly-selected picture was shown on the screen of the 
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laptop in front of the infant. The tester followed the infant’s look on the laptop. If the 
infant looked at the picture, a square like shape (reflection) was visible in his/her pupil. 
At this time the researcher pressed down the left key of the mouse (computer key) and if 
the infant’s eye turned away from the picture the researcher released the key. The 
computer recorded the time between stimulus onset and the look (response latency) and 
the duration of the look. If the infant looked away from the face for 1 second or longer, 
the face was replaced by a blank screen for 2 seconds. The face then reappeared. This 
continued until the criterion for habituation was met, namely two consecutive looks that 
were less than one half the mean duration of the two longest looks. Therefore, the 
minimum number of looks during the familiarization phase was four. After the 
habituation criterion was met, the comparison phase began without interruption of the 
procedure. In the comparison phase, the face that appeared during habituation (the 
“familiar” face) appeared again on one side of the screen and a novel face of the opposite 
gender appeared on the other side. The tester pressed down the left key of the mouse as 
the infant’s eyes looked at the left picture and pressed down the right key of the mouse 
and released the other as the infant’s eyes were looking at the right picture and released 
both fingers as the infant turned away from the pictures. While doing this, the second 
computer has recorded the infant’s looking behavior for reliability testing, while the first 
computer automatically coded the infants’ look duration at the pictures, shifts from one 
picture to the other, and length and number of turns away from the pictures. During the 
comparison phase the faces remained on the screen regardless of whether or not the infant 
was looking at one of them. Once the infant had accrued a total looking time at the faces 
of 5 seconds, the faces were replaced by a blank screen for 1 second, and then the faces 
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reappeared but on opposite sides of the screen. They remained until 5 additional seconds 
of looking accrued.  
This VIP system has already been tested in rural villages near Wolayta by our 
research group.  A generator was used to power the laptops and projector and the system 
worked well. The PI and the tester were trained on the testing of the VIP in the 
Department of Psychology at Oklahoma State University, USA. 
Biomarkers in women 
o Materials 
Samples of urine and breast-milk were collected from mothers for assessment of 
iodine status. Samples of blood were also collected for assessment of thyroid hormones, 
thyroid stimulating hormone and thyroglobulin.  All samples were collected in the 
morning. 
o Procedure 
 Urinary iodine 
Urinary iodine concentration is currently the most practical biochemical marker 
for iodine nutrition because 90% of dietary iodine eventually appears in the urine. 
Urinary iodine concentration can be measured in spot urine specimens from 
representative samples 3. Urine samples were collected in a cup from each participant and 
transferred to fill 2 mL tightly sealed vials in duplicate. Samples were frozen at -20 0C at 
Hawassa University until they were transported to OSU for analysis.  
Urinary iodine was analyzed by inductively coupled plasma mass spectrometry 
(ICP-MS Elan 9000, Perkin Elmer, Norwalk, CT). All urine samples were diluted 10 fold 
(0.5 mL to 4.5 mL) with 2% ammonium hydroxide (NH4OH) (Sigma-Aldrich, St. Lowis, 
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MO) in Millipore water. Standard solutions of iodine were prepared by dilution of 
certified standard solutions (Inorganic Ventures, Christiansburg, VA). Dilute working 
standards were prepared by dilution of an intermediate stock standard solution. The 
calibration standards were prepared in 2% NH4OH solution at 0, 10, 20 and 100 µg/L. 
Tellurium (Perkin Elmer Life and Analytical Sciences, Shelton, CT) was utilized as an 
internal standard. Polypropylene plastic ware was used for standard and sample 
preparation (Sarstedt, Inc., Newton, NC).  
 Creatinine 
Creatinine reagent (Carolina Liquid Chemistries Corp. Brea, CA) for the 
quantitative determination of urine creatinine was analyzed using a BioLis 24i Clinical 
Chemistry Analyzer.  Urinary iodine to creatinine ratio in a single urine sample is 
considered a reliable method to quantify urinary iodine in individuals and is beneficial in 
terms of time, cost and convenience compared to a 24-hr sample 172. 
 Breast milk 
Breast milk iodine concentration is relatively high compared to the UIC of the 
lactating mother even in areas of iodine deficiency 83. Therefore, analysis of iodine 
concentration in breast milk is recommended in order to know the amount of iodine 
consumed by the infant because it is assumed that 95% of the iodine in breast milk is 
absorbed 9. Hence, 10 ml of breast milk were collected from each mother in plastic vials 
for storage.  Samples were frozen at -20 0C until analyzed.  
Breast milk iodine concentration was analyzed by inductively coupled plasma 
mass spectrometry (ICP-MS Elan 9000, Perkin Elmer, Norwalk, CT). Iodine was 
extracted from breast milk using 25% Tetramethylammonium hydroxide (TMAH) 
52 
 
solution (Sigma-Aldrich, St. Louis, MO) and hydrogen peroxide (H2O2). TMAH solution 
(1.5 mL) and H2O2 (0.5 mL) were added to breast milk samples (3 mL) and were mixed 
well. The solution was incubated in an oven at 90 0C for 3 hours using DigiTUBE (CPS 
Science, Baie D’urfé, QC) and after cooling to reach room temperature, the solution was 
centrifuged at 3000 rpm for 15 minutes. All breast milk samples were diluted 25 fold (0.2 
mL to 4.8 mL) with 5% TMAH (Sigma-Aldrich, St. Lowis, MO) in Millipore water. 
Standard solutions for iodine were prepared by dilution of certified standard solutions 
(Inorganic Ventures, Christiansburg, VA). Dilute working standards were prepared by 
dilution of an intermediate stock standard solution. The calibration standards were 
prepared in 5% TMAH solution at 0, 10, 25 and 50 µg/L. Tellurium (Perkin Elmer Life 
and Analytical Sciences, Shelton, CT) was utilized as an internal standard. Polypropylene 
plastic ware was used for standard and sample preparation (Sarstedt, Inc., Newton, NC). 
Non-fat milk powder (RM 1549, National Institute of Standards and Technology, 
Gaithersburg, MD) was used as an external control. 
 Plasma 
Fasting morning venipuncture blood samples were collected from mothers using a 
disposable 10 cc syringe coated with lithium heparin with a 21 gauge needle (Sarstedt, 
Inc., Newton, N.C.). Blood samples were collected using hygienic techniques by an 
experienced lab technician. The blood was centrifuged and plasma was separated. Plasma 
was kept frozen until analyzed for analysis of thyroglobulin (Tg), thyroid hormone 
concentrations (T3 and T4) and thyroid stimulating hormone (TSH).  
Thyroglobulin, TSH and thyroid hormone concentrations were analyzed 
quantitatively based on a double antibody sandwich method (Alpco Diagnostics, Salem, 
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NH). Quality control samples (Bio-Rad Laboratories Inc., Irvine, CA) for Tg, TSH, T3 
and T4 were utilized to verify method performance was within recommended ranges.   
 Goiter  
Total goiter of women was determined by health professional based on the 
following grades: grade 0, no palpable or visible goiter; grade 1, goiter palpable but not 
visible when neck is in the normal position; grade 2, goiter visible when neck is in the 
normal position 39. 
Biomarkers in infants 
o Urinary iodine 
Urinary iodine concentration is a very good indicator to measure infant’s iodine 
status 9. Urine samples were collected from infants by placing cotton balls inside a plastic 
sheet available in the local market. The infants were checked every 10 minutes until urine 
samples were obtained. Urine samples were collected by squeezing urine out of the 
cotton balls. In order to avoid contamination, the health worker who helped with sample 
collection put on new trace mineral free gloves for each infant. Urine samples were 
transferred to fill tightly sealed vials and frozen for subsequent assessment of urinary 
iodine concentration. Samples were stored in a freezer at Hawassa University until 
transported to OSU for analyses. Infant’s UIC and creatinine analysis were done by the 
same method as mother’s UIC and creatinine. 
o Blood 
Blood drops from finger pricks, were collected on a Whatman 903TM specimen 
collection paper (GE Healthcare Bio-Sciences Crop. Westboroght, MA) 9,173. Each 
specimen paper was placed in zip closure with indicating desiccant inside to prevent any 
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moisture build up and stored in freezer until analysis. Drops of blood were collected on a 
slide for hemoglobin analysis. Infants T4 and TSH levels were determined using enzyme 
linked immunoabsorbent assay (Diagnostic Automation Inc., Calabasac, CA) by the 
sequential immunoenzymometric assay procedure. 
- Salt sample 
A 10 g salt sample was collected from each household for iodine content analysis. 
Salt iodine concentration (SIC) was analyzed with a portable digital electronic iodine checker 
(WYD, UNICEF). One gram of salt sample was weighed in 50 ml tube and dissolved with 10 ml 
of distilled water, 2 ml of KI-starch solution and 2 ml of H3P04. Salt was thoroughly dissolved by 
shaking the tube. A small amount of the solution was filled in a cell and the cell was placed in the 
cell holder of the WYD. The concentration (mg/kg) of iodine was directly read out on the LCD of 
WYD iodine checker. A calibrated gray glass provided with WYD was used as a standard instead 
of using standard solution. 
All salt samples were re-analyzed using inductively-coupled-plasma mass spectrometry 
(ICP-MS Elan 9000, Perkin Elmer, Norwalk, CT). A salt sample (1 gm) was diluted with 10 
ml solution of 2% NH3OH (Sigma-Aldrich, St. Lowis, MO) in Millipore water out of 
which 100 µL solution was taken and diluted in 5 ml solution of NH3OH. Standard 
solutions of iodine were prepared by dilution of certified standard solutions (Inorganic 
Ventures, Christiansburg, VA). Dilute working standards were prepared by dilution of an 
intermediate stock standard solution. The calibration standards were prepared in 2% 
ammonium hydroxide solution at 0, 10, 20 and 100 µg/L. Tellurium (Perkin Elmer Life 





- Iodine supplementation 
Iodine capsules that contained 225 µg iodine as potassium iodide (manufactured 
and formulated by Pure Encapsulations, Inc., Sudibury, MA) were purchased and stored 
at room temperature at Hawassa University until all were delivered to the study 
participants. Iodine capsules were delivered to the lactating women daily for 26 weeks by 
the health extension workers and health promoters who lived in the study kebeles.  
Iodized salt was required by government mandate. Before iodized capsules were 
delivered to the women, their household salts were tested for iodine content using rapid 






Table 3.1 Summary of data collection for objective 1 (control and treatment groups) 
Subjects Number of visits & data collection  
 At 0 to 1 week At 26 weeks 
Control groups   









-Measuring weight, height & MUAC 
-Collecting blood, urine & breast milk 
samples 
-Assessing goiter 




-Measuring weight, length, MUAC & 
head circumference 
-Collecting urine & blood samples 
-Measuring VIP 
Distributing supplement of iodized salt 
or capsule as appropriate to the 
experimental design 
Treatment groups   
- Mothers -Recruiting 
-Obtaining consent 
- Questionnaire (interview) 




height & MUAC 
-Collecting blood, urine 
& breast milk samples 
-Assessing goiter 
-Providing iodized oil 
or iodized salt as 
appropriate to the 
experimental design. 
-Collecting blood, urine & breast milk 
samples 
 
- Infants -Measuring weight, 




-Measuring weight, length, MUAC & 
head circumference 
















Subject selection methodology 
Out of the eight kebeles involved in objective 1, one kebele was randomly 
selected to participate in objective 2. A randomized sample of 40 families was drawn 
from the list maintained in the kebele office. All members of each selected household 
were invited to participate in the study. Parental consent was obtained for participation of 
any child under 18 years of age.  Children 12 – 18 years of age provided assent for 
participation. 
Study design 
In one kebele, 40 randomly selected households were assessed for the impacts of 
availability of iodized salt and community iodine awareness on urinary iodine 
concentration (UIC).  At baseline, urine was collected from members of 40 households 
(40 mothers and 76 children) who were available at home during data collection. 
Following that, education was given on consequences and causes of IDD, sources of 
dietary iodine particularly iodized salt, storage and utilization of iodized salt.  All of the 
40 households were provided with one packet of salt (450 g) per week for one month. At 
the end of the month and at two months urine samples were collected from each 
household member who provided urine at baseline.  
Data collection 
o Socioeconomic status (SES) and salt utilization questionnaire 
Socioeconomic status was assessed by a combination of parental education and 
family wealth. Wealth criteria included possession of bicycles, lantern, or mobile phone 
and family ownership of animals and crops, land size, family size, type of home, roof and 
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windows, ownership of umbrella and shoes; children attending school or intention to send 
them; outside employment, water source and latrine. Questions about purchase, storage, 
and utilization of salt were included. Questionnaire was administered orally. 
o Urinary iodine 
Urine samples were collected from adults and children in cups. Urine samples 
were transferred to fill tightly sealed vials and frozen for subsequent assessment of 



















Table 3.2. Summary of data collection for objective 2.  
Subjects Number of visits and data collection 
 At baseline At 1 month At 2 month 
-Parents & children 







salt to the household 
for 1 month 
-Collecting urine 
samples 
-Salt will be tested 
for iodine content 
-Collecting urine 
samples 




























In order to avoid any ethical issues of withholding iodine supplementation for the 
control group, six month old infants were identified and tested towards the end of the 
study to serve as controls. Right after testing, iodized salt was given to the mothers for 26 























Title: Maternal iodine intake and its effect on breast milk iodine, maternal urinary iodine, 
and infants urinary iodine concentrations.  
Abstract 
Iodine deficiency during pregnancy and lactation could expose the infant to 
severe iodine deficiency disorders. This study compared methods of iodine delivery on 
breast milk iodine, and on maternal and infants’ urinary iodine concentrations. An 
experimental randomized supplementation trial in lactating women was conducted. 
Women were randomly assigned either to receive 225 µg iodine as potassium iodide 
capsule daily for six months or 450 g of appropriately iodized salt (30 – 40 µg I as 
KIO3/g of salt) weekly for household consumption for six months. Breast milk iodine and 
maternal and infant urinary iodine were measured at baseline and at six months. Median 
(IQR) breast milk iodine concentration (BMIC) at baseline was 154 (43, 252) µg/L and at 
six months was 105 (36, 198) µg/L, maternal urinary iodine concentration (UIC) at 
baseline was 107 (71, 161) µg/L and at six months was 130 (80, 208) µg/L, and infant 
UIC at baseline was 218 (108, 356) µg/L and at six months was 222 (117, 369) µg/L. The 
women did not differ in BMIC and UIC, and infants did not differ in UIC and 
anthropometric indices in a time by treatment interaction. However, significant 
correlation between the three variables was obtained in both groups at both times. In 
conclusion our findings suggest that appropriately iodized salt (30 – 40 µg I/g) had 
similar effects as a daily supplement of 225 µg I to lactating women on BMIC, maternal 
UIC, and infants UIC. 




Iodine is required for the synthesis of thyroid hormones; thyroid hormones in turn 
regulate the metabolic patterns of most cells. Iodine plays a crucial part in the process of 
early growth and development of most organs, especially the brain 1. Severe maternal 
iodine deficiency during early pregnancy could result in permanent brain damage to their 
offspring 2,3. Mild-to-moderate iodine deficiency could also result in poor learning 
ability, and increased risk of low birth weight, and of infant morbidity and mortality 4. 
Infants under two years of age are among the most vulnerable groups to be affected by 
iodine deficiency along with pregnant and lactating mothers 5. Hence special attention 
has been given to these population groups regarding preventing and controlling iodine 
deficiency 6.  
Risk of iodine deficiency in early infancy is high even in iodine sufficient areas 
because infants’ intrathyroidal reserve turnover rate is rapid 7. Therefore in iodine 
insufficient areas recommendations for iodine for women during pregnancy and lactation 
are increased to 250 µg/d or to a 400 mg single annual dose of iodized oil supplement 8. 
Because a large amount of iodine is secreted into breast milk, exclusively breastfed 
infants 0 – 6 months of age should receive sufficient iodine through breast milk 6,9.  
Recommended intakes for infants are based on mean iodine intake of healthy full-
term infants fed breast-milk, because functional criteria that reflect iodine intake in 
infants are not available. Hence, WHO recommends daily intake of iodine for infants as 
90 µg 10. Similarly, the Institute of Medicine (IOM) in the USA set the adequate iodine 
intake for infants 0-6 months of age at 110 µg/d. This recommendation is based on two 
important points. First, the median BMIC in the United States was 146 µg/L. Second, 
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based on the estimated daily breast milk excretion, the mean amount of iodine obtained 
by an infant from 0.78 L of human milk is approximately 115 µg/d 11. Iodine intake 
greater than the requirement will be excreted in the urine 12. 
Breast milk iodine concentration (BMIC) can be increased by increasing maternal 
iodine intake 12. In a study in 16 healthy lactating US women, BMIC was significantly 
increased after a one time ingestion of 600 µg potassium iodide (456 µg of iodine) as 
measured hourly for eight hours 13. In a randomized, double blind, placebo-controlled 
study, supplementation to lactating women of either 75 µg/d or 150 µg/d of iodine as 
potassium iodate for 6 months significantly increased breast milk and maternal urinary 
iodine concentration (UIC). However the amount of supplementation given was not 
sufficient to improve the mothers’ or infants’ thyroid hormones 14. In another double-
blind, randomized, placebo-controlled trial, one dose of 400 mg of oral iodine as a soft-
gel capsule of iodized poppy seed oil to lactating mothers significantly increased UIC of 
their three-month old infants compared to a single direct dose of 100 mg  iodine given 
orally as an iodized oil supplement to the infants 15. 
As a strategy to alleviate iodine deficiency, increasing iodine intake through 
supplementation or food fortification has been recommended. Salt iodization programs 
have been found to be most useful because they are cost effective and feasible and salt is 
consumed by almost everyone 10. In places where salt iodization is not feasible and/or 
unavailable, iodine supplements should be given to at risk groups including pregnant and 
lactating women or infants 8. Our study aimed to compare efficacy of appropriately 
iodized salt in raising BMIC and maternal and infants UIC compared to daily intake of 
iodine capsules for six months by lactating mothers. 
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Materials and methods 
Data source and study population 
The study was conducted in rural areas of Sidama zone, southern Ethiopia. All 
lactating women (n = 101) in the study village who delivered between January and 
February, 2013 were recruited within a week after delivery to participate in the study. 
Informed consent was obtained from the women for themselves and for their infants. This 
study was conducted in accordance with the ethical principles for the protection of human 
subjects. Ethical approval was obtained from Oklahoma State University (OSU), USA, 
Hawassa University, Ethiopia, and the Ministry of Science and Technology, Ethiopia. 
The study employed an experimental randomized supplementation research design.  
Mother-infant dyads were randomly assigned to receive either 225 µg of iodine as 
potassium iodide in capsule form (Pure Encapsulations, Inc. Boston, MA) daily to the 
mother for six months or 450 g (30 to 40 µg of I as KIO3/g of salt) of iodized salt (I-salt) 
weekly for household consumption for six months. Capsules were delivered to the 
mothers daily or salt for the household was delivered weekly by health extension 
workers. Prior to randomization and delivery of supplements, baseline data including 
anthropometry, urine samples, breast milk samples and socio-demographic information 
were collected from mothers. Infant urine samples and anthropometric measurements 
were also obtained. Following six months of supplementation, similar data were collected 
from mothers and their infants. 
Anthropometry and questionnaire  
Weight (kg) and height (cm) of mothers were measured to calculate body mass 
index (BMI = weight (kg)/height (m)2). Weight was measured on a solar digital scale 
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(Uniscale, UNICEF, NY) and recorded to the nearest 100 g and height was measured to 
the nearest 0.1 cm using a single calibrated instrument (Adult Board, Schorr Productions, 
Olney, MD). Mid upper arm circumference (MUAC) was measured to the nearest 0.1 cm 
using a non-stretchable plastic measuring tape. Weight (Kg) and length (cm) of infants 
were measured to assess growth. Infants’ weight was measured using a Seca 345 infant 
scale and recorded to the nearest 2 g. Infants wore light t-shirts of known weight and laid 
on the scale. Their actual weight was calculated by subtracting the t-shirt weight from the 
total weight. The recumbent length was measured by a length board (Schorr Productions, 
Olney, MD) and recorded to the nearest 0.1 cm. The head circumference and mid upper 
arm circumference were measured using a non-stretchable plastic tape and recorded to 
the nearest 0.1 cm. A questionnaire was administered to assess socio-economic and 
demographic characteristics of the mothers participating in the study. 
Measurement of biomarkers 
Breast milk iodine 
Ten ml of breast milk sample was collected from each mother in plastic vials for 
storage.  Samples were frozen until analyzed. Iodine was extracted from breast milk 
using 25% Tetramethylammonium hydroxide (TMAH) solution (Sigma-Aldrich, St. 
Louis, MO) and hydrogen peroxide (H2O2). TMAH solution (1.5 mL) and H2O2 (0.5 mL) 
were added to breast milk samples (3 mL) and were mixed well. This solution was 
incubated in an oven at 90 0C for 3 hrs using DigiTUBE (CPS Science, Baie D’urfé, QC) 
and after cooling to room temperature, the samples were centrifuged at 3000 rpm for 15 
minutes. All breast milk samples were diluted 25 fold (0.2 mL to 4.8 mL) with 5% 
TMAH (Sigma-Aldrich, St. Lowis, MO) in Millipore water.  Breast milk iodine 
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concentration was analyzed by inductively coupled plasma mass spectrophotometer (ICP-
MS, Elan 9000, Perkin Elmer, Norwalk, CT). Tellurium (Perkin Elmer Life and 
Analytical Sciences, Shelton, CT) was utilized as an internal standard. Non-fat milk 
powder (RM 1549, National Institute of Standards and Technology, Gaithersburg, MD) 
was used as an external control. 
Urinary iodine 
Mothers collected their own urine in a cup out of which samples were taken to fill 
2 mL tightly sealed vials in duplicate. Urine samples were collected from infants by 
placing cotton balls appropriately inside a plastic sheet available in the local market. The 
infants were checked every 10 minutes until urine samples were obtained. Urine samples 
were collected by squeezing urine out of the cotton balls. In order to avoid contamination, 
the health worker who helped with sample collection put on new trace mineral free 
gloves for each infant. Samples were frozen at -20 0C at Hawassa University and then 
transported to OSU for analysis.  Urinary iodine was diluted in 2% ammonium hydroxide 
and analyzed by inductively coupled plasma mass spectrophotometer (ICP-MS, Elan 
9000, Perkin Elmer, Norwalk, CT), with tellurium as internal standard.  
Urinary creatinine 
Creatinine reagents (Carolina Liquid Chemistries Corp., Brea, CA) were 








The main outcome variables in this study were BMIC, maternal and infants’ UIC 
and infants’ anthropometric measurements. All data were checked for normality using 
Kolmogorov-Smirnov test and skewed data were log transformed before analysis.  
Weight-for-age Z score (W/A Z score), weight-for-length Z score (W/L Z score) 
length-for-age Z score (L/A Z score) and head-circumference-for-age Z score (HC/A Z 
score) of infants were calculated using the WHO Anthro software (version 3.2.2., 2011; 
WHO, Geneva, Switzerland). The time and treatment effect was assessed by linear mixed 
effect model analysis for repeated measures. 
Correlations between outcome variables were assessed using Pearson’s 
correlation for normally distributed data or Spearman’s rho for non-normally distributed 
data. The relation between multiple variables and infant’s UIC were modeled by multiple 
linear regression. Variables for regression were chosen based on correlation. Data are 
reported as mean (SD), median (25th, 75th percentile), or percentage (frequency) as 
appropriate. Level of significance was set at p < 0.05. SPSS (version 20; IBM Corp. 
Armonk) and SAS (Version 9.3; SAS Institute Inc., Cary, NC) were used for data 
analysis. 
Results 
Characteristics of study participants at baseline 
All of the women who participated in the study exclusively breastfed in the first 
week after delivery and continued breast feeding to six months. However only 58% 
reported exclusive breast feeding at the age of six months (data not shown). The mean 
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frequency of breast feeding in the 24 hours preceding the survey in both groups was 12.8 
(5.2) (Table 1).  
Mother-infant dyads in the iodine capsule and I-salt groups did not differ in any of 
the socio-demographic characteristics presented in Table 1. Therefore, Table 1 shows 
both groups (capsule and I-salt groups) combined. The median age of the mothers was 22 
(20, 25) years. The mothers’ BMI was 21.5 (2.3) kg/m2 and MUAC was 23.3 (1.7) cm. 
The mean gravidity and parity were 3 (2) and the mean household size was 6 (2.2). 
Mothers attended 3.8 (3.5) school years on average.  
The median age of the infants at baseline was 6 (4, 8) days. There were 50 male and 51 
female infants enrolled in the study.  
Breast milk and urinary iodine concentration of mothers and their infants 
Table 2 shows baseline and six months values for BMIC of mothers and UIC of 
mothers and their infants. The women were not significantly different in BMIC or UIC 
and the infants were not significantly different in UIC at the two time points. Because our 
data showed a large within group variation, we categorized BMIC into different groups as 
indicated in Table 2. At baseline 25.7% of the women had BMIC <50 µg/L, 22.8% had 
50 – 149 µg/L, 26.7% had 150 – 250 µg/L and 24.8% had > 250 µg/L. At the end of the 
study at six months 31.7% of the women had BMIC < 50 µg/L, 32.7% had 50 – 149 
µg/L, 21.8% had 150 - 250 µg/L and 13.9 % had > 250 µg/L. BMIC was lower at six 
months but there was no significant time by treatment interaction (p = 0.656). Of the 
women 11% and 10% had UIC below 50 µg/L at baseline and at six months respectively.  
According to the WHO classification for iodine deficiency in lactating women, 
47.5% of the women were iodine deficient (UIC < 100 µg/L) at baseline and 38.6% were 
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deficient at six months. Median UIC appeared to be slightly higher at six months but 
there was no time by treatment interaction (p = 0.668). Based on the median UIC, the 
mothers in both groups showed similar changes; the capsule group remained in the iodine 
sufficient category and the I-salt group moved from the iodine deficiency category 
(median UIC = 95 µg/L) to the iodine sufficient category (median UIC = 110 µg/L). Also 
maternal UIC adjusted for creatinine was not significantly different between groups or 
over time (p = 0.748). 
The proportion of infants with UIC < 100 µg/L at baseline was 20.8% and at six 
months was 15.8%. The median UIC of infants was not significantly different in time by 
treatment interaction (p = 0.322) (Table 2). 
As shown in Figure 1, UIC of infants at baseline was higher than BMIC (p < 
0.001) and than maternal UIC (p < 0.001). Similarly, at six months, UIC of infants was 
higher (p<0.001) than maternal UIC and BMIC. Maternal BMIC was not significantly 
different from UIC at either baseline or endpoint.   
Infants’ anthropometric indices were calculated at baseline and at six months. 
Infants did not differ in any of the indices between groups. As shown in Figure 2, infants 
L/A Z-score was significantly decreased at six months (p < 0.0001) compared to baseline.  
The means of the three indices in both groups were above the cut-off for nutritional 
deprivation. However, some infants showed nutritional deprivation and this is illustrated 
in Figure 3.  
Relations between BMIC, maternal UIC and infants UIC at six months were 
examined. As indicated in Figure 4A and 4B, BMIC was significantly correlated with 
maternal UIC (r = 0.39, p < 0.001) and infants UIC (r = 0.44, p < 0.001). The correlation 
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between BMIC and maternal UIC increased when maternal UIC was adjusted for 
creatinine as shown in Figure 4C, (r = 0.51, p < 0.001). Maternal UIC was correlated with 
infants UIC as shown in Figure 4D, (r = 0.31, p < 0.001). The correlation coefficients at 
baseline were similar to those illustrated at six months.  
In Table 3, multiple regression models with four best-fitting variables predicting 
infants UIC are presented. The model at baseline with all four predictors produced an 
adjusted R2 = 0.290 and at six months the model adjusted R2 was 0.286. At baseline 
maternal UIC/Creatinine, BMIC and infant sex had significant regression weights, 
indicating infants whose mothers had higher maternal UIC and BMIC were expected to 
have high UIC and females were expected to have lower UIC than males. At six months 
maternal UIC adjusted for creatinine, BMIC and infants age had significant regression 
weights, indicating infants whose mothers had higher UIC and higher BMIC were 
expected to have higher UIC. Moreover, at six months, a one day increase in infants age 




This study showed BMIC, maternal UIC and infants UIC were not significantly 
different between mothers who received 225 µg of iodine daily as a capsule for six 
months in addition to variable amounts (0 to 42 ppm (mg/kg)) of iodine in their existing 
household salt and mothers who received 450 g per household of appropriately iodized 
salt delivered weekly for six months. It was estimated that the average salt intake in 
Ethiopia nationally was 8.4 g and in the study region was 17.2 g per person per day 
which is more than two fold the national intake 16. One reason the salt intake in this 
region is high is because people in the rural areas consume salt in their coffee several 
times a day in addition to other food items. From our follow up observation however, the 
amount of salt we provided (450 g) was enough for one week. 
The dose of 225 µg of iodine provided was at the lower end of the recommended 
range  for lactating women (225 to 350 µg daily) 17. Measured iodine concentration of the 
salt was 30 to 40 mg KIO3/kg of salt, consistent with the recommendation of the World 
Health Organization 18.    
Infants’ anthropometry was not different between groups for all indices. In all of 
the infants combined, length-for-age Z score was significantly decreased (p < 0.0001) at 
six months which indicates infants did not grow appropriately. The reasons for decline in 
growth could be various including multiple micronutrient deficiencies, infectious diseases 
and others. 
Maternal iodine intake is critical during lactation in order to provide the 
breastfeeding infant’s iodine requirement. Iodine is concentrated through the sodium 
iodide symporter mechanism, which promotes increased expression of iodine in milk 
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during lactation 19. Thus, iodine is present in breast milk at higher concentrations than in 
plasma 20. 
Iodine intake recommendations for infants up to six months of age are based on 
estimates of the amount provided by breast milk of well-nourished women. The average 
milk excretion is estimated to be 0.78 liter per day during the first 6 months of infancy. In 
iodine sufficient women (estimated to have a mean iodine consumption of 290 µg/d), this 
amount of breast milk would provide a mean of 114 µg of iodine 11. In our study the 
median BMIC (154 (43, 252) µg/L) at baseline was within the normal range of 150 to 
180 µg/L in iodine sufficient countries 21,22. If the average daily milk volume was 0.78 
L/day as estimated by IOM, the infants would receive a mean of 120 µg iodine per day.   
Despite iodine supplementation of 225 µg daily or well iodized salt weekly for six 
months, median BMIC decreased from 154 (43, 252) µg/L at baseline to 105 (36, 198) 
µg/L at six months. Consistent with our study, Mulrine et al (2010) found that BMIC 
declined over the first 24 weeks in non-supplemented lactating women and 
supplementation with 75 µg or 150 µg of iodine daily did not increase BMIC to a level 
that could raise infants median UIC. In the women who received 75 µg of iodine, BMIC 
ranged between 35 to 57 µg/L and infants UIC was 50 (22, 60) µg/L. In the group who 
received 150 µg, BMIC ranged between 43 to 70 µg/L and infants UIC was 66 (36, 87) 
µg/L 14. In another study, BMIC in non-supplemented mothers declined from 43 µg/L at 
baseline to 26 µg/L over a nine months period while milk from the supplemented mothers 
declined from 41 µg/L at baseline to 39 µg/L at nine months 15.  
It should be noted that our baseline data was collected within one week (with 
more than 32% within four days) after delivery, when colostrum was still available. 
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Iodine concentration is high in colostrum and decreases over time until it reaches a  point 
where it becomes steady in mature milk 21. Because the decrease in iodine concentration 
in breast milk over time has not been measured in detail, it is difficult to quantify the 
effect our supplementation had on maintaining BMIC.  
Our data showed a wide range in BMIC at baseline as well as at six months. At 
baseline the BMIC ranged from 8 µg/L to 965 µg/L with 49% below 150 µg/L. At six 
months the range was from 4 µg/L to 958 µg/L with 64% below 150 µg/L. In a study in 
50 Korean women, whose diets frequently included sea-weed soup, considerable 
elevation and range of BMIC from 198 to 8484 µg/L was reported 23. Significant 
variation of BMIC ranging from 5 to 2170 µg/L 22 and from 9 to 1267 µg/L 21 were also 
reported in two other reviews. This variation indicates that many infants may not get 
adequate amounts of iodine to meet their requirement. Moreover, of the women who had 
UIC > 100 µg/L, which is considered adequate for lactating women, 37% had BMIC < 
150 µg/L.  
Maternal median UIC was numerically high but not significantly different 
between the two types of iodine supplement. However, on the basis of the median UIC 
value of 100 µg/L for iodine sufficiency, the mothers in the I-salt group had increased 
their median UIC from 95 µg/L which indicated iodine deficiency to 110 µg/L which 
indicated iodine sufficiency. Based on the range (150 – 230 µg/L) of median maternal 
UIC as an indicator for optimal iodine nutrition during lactation 17, most of our study 
participants in both groups fell below the minimum value at baseline. Following six 
months of iodine supplementation however, most of the women in the capsule group met 
the minimum range whereas the women in the I-salt group remained below the range. For 
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the whole group at six months the median BMIC of those mothers with UIC below 150 
µg/L was 83 µg/L and above 150 µg/L was 133 µg/L. This could indicate the dose given 
to these women might have been inadequate to raise iodine status.  
The median maternal UIC of 107 µg/L at baseline indicated an improvement in 
the iodine status of the population because Ethiopia, including the study population, has 
been moderately to severely iodine deficient for decades (Median UIC ranged between 1 
µg/L to 89 µg/L) 24-28. Therefore, the change observed in this study can be attributed  to  
the recently implemented salt iodization program in the country 29. 
The proportion of women with median UIC below the cut-off value for iodine 
sufficiency decreased by 10% (from 42% to 32%) in the capsule group and by 8% (from 
53% to 45%) in the I-salt group between baseline and the end of the study. A double-
blind, randomized, placebo-controlled study reported a 14% increase in UIC at six 
months after giving the lactating mother a 400 mg iodized oil capsule 15. The study in 
New Zealand showed that a daily supplement of either 75 µg or 150 µg of iodine daily 
for six months during lactation increased maternal UIC significantly but maternal UIC 
remained below 100 µg/L 14. On the contrary, a study conducted in Thailand reported 
median UIC of lactating women (199 µg/L), who received a multivitamin/mineral tablet 
that contained 200 µg of iodine daily for the second and third trimesters of pregnancy 
was not significantly different from non-supplemented women (120 µg/L) at two months 
postpartum. This could be due to the increased salt iodization coverage observed  in the 
country during the study period 30. In the current study, although the UIC increase was 
not significant, the proportion of women with UIC above 150 µg/L was increased from 
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40% at baseline to 50% at six months in the capsule group and from 20% at baseline to 
43% at six months in the I-salt group. 
The recommended dietary intake (225 - 350 µg) of iodine daily for lactating 
mothers and 90 µg of iodine daily for neonates and infants was set on the basis that when 
these requirements are met the expected UIC output in the neonates and infants would be 
180 - 225 µg/L 17. In the current study UIC of infants was within the range of the 
expected outcome in both groups and at both times. Surprisingly the median UIC of 
infants obtained in this study was high (218 µg/L at baseline and 222 µg/L at six months) 
compared to iodine sufficient countries except the USA, which was 921 µg/L. In the rest 
of iodine sufficient countries infants median UIC was 162 µg/L in The Netherlands, 148 
µg/L in Canada, and 112 µg/L in Sweden 12.  
The median infants UIC at baseline was significantly higher than BMIC (p < 
0.001) and maternal UIC (p < 0.001) and although not significant median BMIC was 
higher than maternal UIC. This pattern was similar to other studies that reported these 
variables 14,15. The majority of iodine in lactating women is excreted in the breast milk; 
infants need small amounts to meet their daily requirement, and the remaining iodine will 
be excreted in their urine supporting this pattern 12,17. 
Significant correlations were obtained between maternal UIC, BMIC and infants 
UIC (Figure 4). The correlation between maternal UIC and BMIC increased when 
maternal UIC was adjusted for creatinine. A study conducted in Denmark reported that 
urinary iodine predicted BMIC more precisely when it was adjusted for creatinine 31. 
Another study reported that urinary iodine was not associated with median thyroid 
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stimulating hormone (TSH) and thyroxine (T4) but was significantly associated when it 
was adjusted for creatinine 32.  
In our regression model at baseline, maternal urinary iodine adjusted for 
creatinine and BMIC were positive predictors (p = 0.002 and p = 0.006 respectively) and 
infants sex was a negative predictor (p = 0.046) of infants UIC. At six months maternal 
urinary iodine adjusted for creatinine and BMIC were positive predictors (p < 0.001 and 
p = 0.001 respectively) and infants age was a negative predictor (p = 0.014) of infants 
UIC. This is consistent because as infants grow older the likelihood increases that they 
will not be exclusively breastfed.  
This study compared the results from providing salt iodized at the level 
recommended by WHO with a daily supplement of 225 µg as an iodine capsule in 
addition to household salt on BMIC and maternal and infants UIC. Most studies have not 
compared these three major outcome variables.  The method we used to collect infants 
urine samples was cost effective and feasible. Thus far there was only one study that 
reported breast milk iodine content (in a range of 5 to 16 µg/L) in Ethiopia, at a time that 
only 4.2% of households consumed iodized salt 28. The study used the Moxon and Dixon 
method 33 which requires dry-ashed milk sample which we think could cause loss of 
iodine before analysis. Other strength of this study is that we recruited all of the women 
who delivered within the data collection time period.  
We analyzed water iodine concentration in this study and all of the water samples 
from different sources were below the detection limit of 1 µg/L (Data not shown). As it is 
well known the only source of iodine in the study population is iodized salt. As infants 
begin to get a higher percent of energy from low iodine complementary foods, their total 
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iodine intake will go down. In Ethiopia in general and in the study region (SNNPR) in 
particular, the median duration of exclusive breastfeeding was 2.3 and 2.2 months 
respectively 34. 
 The limitation of this study is that we did not analyze iodine content of 
complementary food. This is important because starting complementary food early 
affects frequency of breastfeeding and this affects the amount of iodine which could go to 
the infant through breast milk 35.  However, the increase in infant UIC at six month 
indicates iodine intake increased. 
Conclusions 
In conclusion our findings suggest that appropriately iodized salt (30 – 40 µg I as 
KIO3/g) had a similar effect on BMIC and maternal and infants UIC as a daily 
supplement of 225 µg I as potassium iodide to lactating women. As a way to combat 
iodine deficiency disorders, universal salt iodization has been recommended. However, it 
is important to ensure that the salt is homogenously iodized and contains the required 
amount. The salt used in this study was iodized for research purposes. The special order 
was required because the salt sold in the Ethiopian market at the time of the study varied 
notably in a range of 0 to 42 ppm (data not shown) which would result in variable iodine 
intake. Despite the variability however, the recently implemented salt iodization program 
in Ethiopia seems to show promising progress. Although data are limited on  previous 
breast milk iodine concentrations  in the country,  the iodine concentration obtained in the 
study participants would put Ethiopia among the iodine sufficient countries 12. However, 




Salt is recommended as the best vehicle for delivery of iodine, but attention needs 
to be given to quality control for iodization and to losses through storage, cooking and 
handling processes 10. How much iodine is lost through these processes is not clear, but 
well-designed research is required to evaluate losses and to identify strategies to avoid 
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• Appropriately iodized salt (30 – 40 µg iodine as KIO3/g of salt) showed similar 
effects as 225 µg of potassium iodide on BMIC, and maternal and infants’ UIC.  
• The median BMIC and infants’ UIC obtained in this study were similar to those in 
iodine sufficient countries. 
• Exclusive breast feeding while consuming salt iodized at levels recommended by 
WHO could provide an infant with sufficient amounts of iodine. 
• Salt should be adequately and homogenously iodized in order to ensure appropriate 
intakes of iodine. 
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Fig. 2A. Length-for-Age Z-scores of infants 
at baseline & six months
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Fig. 2B.  Weight-for-length  Z-score of 

















Fig. 2C . Weight-for-age Z-score of infants 
at baseline and six months 















Fig. 2D.  Head circumference-for-Age Z-


















































Fig. 3. Nutritional deprivation of infants at baseline & at six months 
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Fig 4A. BMIC & maternal UIC at 6 months (n = 101)
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Median, mean, or 
% 
Mothers  
- Age (y) 22 (20, 25) 
- MUAC (cm) 23.3 (1.7) 
- BMI (kg/m2) 21.5 (2.3) 
- Gravidity 3 (2) 
- Parity 3 (2) 
- School years 3.8 (3.5) 
- Household size 6 (2.3) 
- Frequency of breast feeding 
last 24 hours 
12.8 (5.2) 
Infants  
- Age (days) 6 (4, 8) 
- Sex  
     - Male 49.5%  
     - Female 50.5%  
Data are median (IQR), mean (SD), % (n/N).  







Table 2. BMIC and UIC of mothers and infants in subjects who received iodine as a 
capsule  (n = 50) or iodized salt (n = 51) 
 
 Capsule group I-salt group 
Mothers Baseline 6 months Baseline 6 months 
BMIC (µg/L) 149 (46, 266) 104 (39, 197) 157(29, 243) 111 (34, 202) 
BMIC < 50 µg/L 26% 34% 25% 29% 
BMIC 50 - 149 µg/L 24% 30% 22% 35% 
BMIC 150 – 250 
µg/L 
22% 22% 31% 22% 
BMIC > 250 µg/L 28% 14% 22% 14% 
UIC (µg/L) 136 (76, 173) 150 (86, 220) 95 (64, 142) 110 (73, 191) 
UIC < 100 µg/L 42% 32% 53% 45% 
UIC ≥ 100 µg/L 58% 68% 47% 55% 
I/Cre (µg/L) 214 (142, 
292) 




Infants      
UIC µg/L 234 (121, 
379) 




UIC < 100 µg/L 16% 8% 18% 23.5% 
UIC ≥ 100 µg/L 84% 92% 82% 76.5% 
Data are median (IQR) or percentage. Continuous data were analyzed using a mixed 
effects model. BMIC: breast milk iodine concentration, UIC: urinary iodine 






Table 3. Multiple regression predicting UIC of infants at baseline and 6 months (n = 101) 
 Baseline At 6 months 
Variables     β    p    β    p 
Maternal UIC/Creatinine 0.297 0.002 0.407 0.000 
BMIC 0.258 0.006 0.251 0.001 
Infant’s age -0.158 0.083 0.174 0.014 
Infant’s sex -0.180 0.046 -0.081 0.123 
Adjusted R-square 0.290 0.286 
The dependent variable (Infants UIC) and the independent variables including maternal 
UIC/Creatinine and BMIC were analyzed as log transformed data because they were not 
normally distributed. 
















Title: Maternal iodine supplementation during lactation and its effect on maternal and 
infant thyroid function and infants visual information processing  
Abstract 
Iodine deficiency is a major global public health problem, which has particularly severe 
consequences in pregnant women and young children. Iodine deficiency is one of the 
major causes of preventable brain damage in childhood. However, iodine 
supplementation during early pregnancy and lactation can prevent the ill effects of iodine 
deficiency. The objective of this study was to assess the effect of iodine supplementation 
on mothers and infants thyroid function and infants visual information processing (VIP). 
A community-based, randomized, supplementation trial was used. Mother infant dyads (n 
= 106) were recruited within the first week after delivery to participate in this study. 
Study participants were randomly assigned either to receive a potassium iodide capsule 
(225 µg iodine) daily for 26 weeks or appropriately iodized salt weekly for 26 weeks. 
Lactating women (n = 53) who had 26 week old infants were recruited to serve as a 
control group. Maternal thyroxine (T4), triiodothyronine (T3), thyroid stimulating 
hormone (TSH), thyroglobulin (Tg), urinary iodine concentration (UIC), breast milk 
iodine concentration (BMIC) and infant T4, TSH, UIC and VIP were measured as 
outcome variables. At baseline, mother infant dyads in the two groups (capsule and 
iodized salt (I-salt) groups) were not significantly different in any of the biomarkers and 
anthropometry measurements. Maternal TSH and goiter rate significantly decreased 
following iodine supplementation. Infant T4 was significantly different between groups (p 
< 0.001). The percentage of infants who showed novelty preference above 0.55 to new 
stimuli in the capsule, salt and control groups were 26%, 51% and 47% respectively. 
However, VIP tests did not show any significant differences between groups. In 
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conclusion, a dose of 225 µg of iodine supplement and initiating supplementation during 
lactation may not be enough to affect thyroid and brain function in the infant. 




Iodine is essential for the synthesis of thyroid hormones, and thyroid hormones 
regulate the metabolic processes of most cells and play important roles in human growth 
and development 1. Iodine deficiency is a major global public health problem, and it is 
one of the most severe causes of preventable brain damage in childhood 2.  
While thyroid hormone is essential for development of several neurological 
functions the timing of its deficiency also determines the type of deficit 3. Thyroid 
hormone deficiency during early pregnancy may affect visual processing, motor, and 
visuomotor skills whereas deficiency in the early neonatal period may affect visuospatial 
abilities. If the problem extends to the postnatal period and further in infancy it may 
affect sensory motor, language, fine motor, auditory processing, attention and memory 
skills. Late treatment may result in deficits in executive processing during childhood 3.  
On the other hand, iodine supplementation during early pregnancy and lactation 
could prevent the deleterious effects of iodine deficiency 4.  During these developmental 
periods, the mother is the only source of iodine to the fetus and neonate 5. The fetus gets 
T4 from the mother in order to produce T3 (active thyroid hormone) which indicates the 
importance of early intervention 4-6. In areas of severe iodine deficiency, iodine 
supplementation to pregnant women produced better psychomotor development scores 
and higher IQ scores in the offspring compared to the offspring of non-supplemented 
pregnant women 6.  In Papua, New Guinea, an injection of intramuscular iodine before 
conception eliminated endemic cretinism 7.  
Nonetheless, although previous studies confirmed the beneficial effects of iodine 
in improving cognition, recent research findings are showing inconsistent results. In a 
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mildly iodine deficient population in New Zealand and Albania, iodine supplemented 
children had better motor performance and information processing rates compared to 
placebo 8,9. However, in another study in Spain, an iodine supplement of 200 or 300 µg 
daily to women in their first trimester did not show any significant change in either 
mental development or psychomotor development scales (PDS) in infants between the 
ages of 6 and 18 months 10. Furthermore, a study from Spain reported that infants (1 year 
of age) of mothers who received iodine supplement > 150 µg/day scored lower on the 
PDS than infants of women who received < 100 µg/d of iodine supplement 11. 
The inconsistent results could be for various reasons. When measuring 
psychomotor or mental development it is crucial to identify the appropriate measurement 
instrument that is sensitive enough to detect the targeted outcome. The Institute of 
Medicine has developed seven criteria in choosing appropriate measurement instruments. 
These include, age appropriateness, potential long-term consequences, sensitivity, brain-
behavior links, cross-species generalizability, function specificity, and ease of 
administration 12. 
One of the best known and most widely used tests of infant development is the 
Bayley Scales of Infant Development (BSID). However the BSID is generally good an 
overall measure of infant development but unable to predict latter IQ 13,14. On the other 
hand visual information processing (visual recognition memory) is the beginning of 
cognitive function which can predict broad cognitive abilities in later childhood 15,16. 
Moreover, this measure can be administered during the first year 14, has links to the 




In the current study we assessed infant cognitive function using a visual 
information processing (VIP) paradigm. The objective of this study was to assess the 
effect of iodine supplementation on mothers and infants thyroid function and on infants 
VIP.  
Materials and methods 
 
Subjects and study design 
 
The study was a community-based, randomized, supplementation trial conducted 
in 2013. Participants for this study were selected from women and their infants living in 
rural areas of Sidama zone, southern Ethiopia. The study population depends on 
subsistence farming for their livelihood. Their major staple food is enset (Enset 
ventricosum) followed by unrefined maize 19. The area was known for severe iodine 
deficiency prior to implementation of salt iodization in 2012 20-22. 
Subject selection methodology 
A total sample size of 159 mother-infant dyads was calculated using an alpha of 
0.05, 80% power and an effect size of 0.25. For selecting participants two important 
criteria were set. First, the women must be lactating and must have an infant of a specific 
age:  a) less than or equal to one week old for the treatment group, or b) 6 ± 0 .25 months 
old for the control group.  Second, they had to volunteer to participate in the study. Based 
on these criteria, all mother-infant dyads who met the criteria were invited and enrollment 
was continued until the required sample size was attained.   
Exclusion criteria 
The exclusion criteria for mothers in this study were any hyperthyroidism 
symptoms manifested by nervousness, anxiety, heart palpitations, rapid pulse, 
fatigability, tremor, muscle weakness, weight loss with increased appetite, heat 
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intolerance, frequent bowel movements, or increased perspiration 23.  If infants had fever, 
cough or severe (>3/day) diarrhea, the mother-infant dyad would not be enrolled in the 
study. If mothers showed any allergic reaction such as acne, weakness, or foul breath 
after supplementation was started they were excluded from the study as well. But none of 
the subjects showed any of the symptoms. 
Because the ethics rules at Oklahoma State University, USA and Hawassa 
University, Ethiopia did not allow a control group with no iodine supplement for study 
purposes, we did not begin the control group with infants less than one week of age.  
Instead we recruited mothers and their 6 ± 0.25 month old infants to serve as a control 
group for our treatment groups at 6 months of age. 
Ethical clearance 
Ethical approval was obtained from Oklahoma State University, USA, Hawassa 
University, Ethiopia, Ministry of Science and Technology, and Food, Medicine, and 
Health Care Administration and Control Authority of Ethiopia. Following receipt of 
ethical clearance, study participants were enrolled with the help of health extension 
workers working in the study area. Study participants were given a detailed explanation 
of the objectives of the research and consent was taken from the women for themselves 
and their infants before data collection was started.  
Randomization 
Of the 159 women recruited, 53 women who had 6 ±0.25 month-old infants were 
designated as the control group and the remaining 106 mother-infant (<1 wk of age) 
dyads were randomly assigned either to the iodine capsule group or to the iodized salt (I-




The capsule group (n = 50) received 225 µg of iodine daily as a capsule of 
potassium iodide (Pure Encapsulations, Inc. Boston, MA) for 26 weeks. Iodine capsules 
were delivered daily to mothers by health extension workers. The I-salt group was 
provided with iodized salt with 30 to 40 µg/kg of KIO3 (1 packet (450 g) of salt per week 
per household) for 26 weeks. (Guts Agro Industry PLC, Addis Ababa, Ethiopia). 
Supplementation was started within one week of delivery of the infant and continued for 
26 weeks.  
Prior to beginning supplementation, baseline data were collected from both 
mothers and infants. From mothers, urine, breast milk and blood samples and urine 
samples from infants were collected. Blood samples were collected from each woman 
using a disposable 10 cc syringe coated with lithium heparin with a 21 gauge needle 
(Sarstedt, Inc., Newton, N.C.). The blood was centrifuged and plasma was separated 
immediately. Plasma was kept frozen at – 20 0C and was used for analysis of thyroid 
hormone concentrations (T3 and T4), thyroid stimulating hormone (TSH) and 
thyroglobulin (Tg). 
Mothers collected urine in a cup out of which urine samples were taken to fill 
tightly sealed vials in duplicate. Ten ml of breast milk samples were collected from each 
mother in a plastic vial for storage.  Infant urine was collected by squeezing urine out of 
cotton balls in a disposable diaper; urine samples were transferred to tightly sealed vials. 
All samples were frozen for subsequent assessment of iodine concentration.  
Goiter of each woman was determined by palpation based on the following 
grades: grade 0, no palpable or visible goiter; grade 1, palpable goiter but not visible 
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when neck is in the normal position; grade 2, visible goiter when neck is in the normal 
position 24. Goiter grade was determined by a health professional. 
Maternal anthropometry including weight and height to calculate body mass index 
(BMI = Wtkg Htm2), and mid upper arm circumference (MUAC) were measured. Infant 
anthropometry including head circumference, MUAC, weight and length were measured. 
Infant’s weight-for-age (WAZ score), length-for-age (LAZ score), weight-for-length 
(WLZ score), MUAC and head circumference were calculated using WHO Anthro 
software (Version 2.0.4). 
Mothers were interviewed using an individual questionnaire adapted from the 
Ethiopian Demographic and Health Survey Agency. The questionnaire included 
socioeconomic status and demographic characteristics of women 25.  
Following 26 weeks of supplementation, samples similar to baseline were 
collected from both mothers and infants of the two treatment groups (Capsule and I-salt). 
At 26 weeks similar samples were also collected from a control group. Moreover, after 26 
weeks blood samples were collected from all infants in the three groups by finger prick 
on specimen paper for TSH and T4 analysis and infants were tested using the VIP test.  
Administration of visual information processing (VIP)  
Materials 
For the VIP, eight pictures of young adult Ethiopian faces without emotional 
expression (four male and four female) were used. Two laptop computers were used. One 
laptop computer was used to control the presentation of stimuli. A second computer that 
had a built-in camera was used to follow and record the infant’s looking behavior. 
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Although the infant’s looking behavior was coded live, the looking process was recorded 
on this second computer for later reliability testing.  
Procedure 
A quiet room was prepared for administration of the VIP test. The infant sat on 
the mother’s lap in front of the camera, eyes forward, and half a meter away from the 
screen. A bed sheet was placed between the VIP tester and the infant and hence the 
researcher was out of sight of the infant. The tester (who was blind to the study) adjusted 
the visibility and focus of the infant’s face and eyes on the laptop that had the camera. 
Once the focus was adjusted, the familiarization phase began. A randomly-selected 
picture was shown on the screen of the laptop in front of the infant. The tester followed 
the infant’s look on the laptop. If the infant looked at the picture, a square like shape 
(reflection) was visible in his/her pupil. At this time the tester pressed down the left key 
of the mouse (computer key) and if the infant’s eye turned away from the picture the 
tester released the key. The computer recorded the time between stimulus onset and the 
look (response latency) and the duration of the look. If the infant looked away from the 
face for one second or longer, the face was replaced by a blank screen for two seconds. 
The face then reappeared. This continued until the criterion for habituation had been met, 
namely two looks that were less than one half the mean duration of the two longest looks. 
Therefore, the minimum number of looks during the familiarization phase was four. After 
the habituation criterion had been met, the comparison phase began without interruption 
of the procedure. In the comparison phase, the face that appeared during habituation (the 
“familiar” face) appeared again on one side of the screen and a novel face of the opposite 
gender appeared on the other side of the screen. The tester pressed down the left key of 
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the mouse as the infant’s eyes were looking at the left picture and pressed down the right 
key of the mouse and released the left as the infant’s eyes looked at the right picture.  The 
tester released both fingers as the infant turned away from the pictures. While doing this, 
the second computer recorded the infants’ looking behavior for reliability testing, while 
the first computer automatically coded the infant’s look duration at the pictures, shifts 
from one picture to the other, and length and number of turns away from the pictures. 
During the comparison phase, the faces remained on the screen regardless of whether or 
not the infant was looking at one of them. Once the infant accrued a total looking time at 
the faces of 5 seconds, the faces were replaced by a blank screen for 1 second, and then 
the faces reappeared but on opposite sides of the screen. They remained until an 
additional 5 seconds of looking had accrued.  
Visual recognition memory is composed of various constructs. Novelty preference 
was used to measure recognition memory and speed of processing 26. Look duration was 
a measure of processing speed and attention 27, average look duration measures the speed 
at which recognition was achieved 28 and total shift was used as a measure of how active 
the infant was in looking back and forth between the two faces in order to compare them. 
A reliability test was performed by a University student who was blind to the study. This 
involved the student independently coding the recorded videos of randomly selected 30 
infants. Reliability was then calculated as the correlation between the original coding and 
the reliability coding. 
Measurement of biomarkers 
Urinary iodine concentration (UIC) and BMIC were analyzed by inductively 
coupled plasma mass spectrometer (ICP-MS Elan 9000, Perkin Elmer, Norwalk, CT). 
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Detailed analysis methods for UIC and BMIC are described elsewhere. Creatinine was 
analyzed using a BioLis 24i Clinical Analyzer (Carolina Liquid Chemistries Corp. 
Winston-Salem,NC). Total thyroxine (T4), total triiodothyronine (T3), thyroid stimulating 
hormone (TSH) and thyroglobulin (Tg) were quantitatively determined by ELISA assay 
(ALPCO Diagnostics, Salem, NH). Quality control for T4 and T3 was obtained from Bio-
Rad Laboratories (Irvine, Ca). Infant’s T4 and TSH also were determined by ELISA 
assay (Diagnostic Automation, Calabasas, CA). 
Statistical analysis 
Data were analyzed using selected descriptive and analytical statistical measures. 
In the descriptive section percentages, frequency distributions, means (SD) and medians 
(IQR) were used to describe the socio-economic status, demographic characteristics, and 
iodine status of lactating mothers and their infants. All data were checked for normal 
distribution and skewed data were log-transformed before analysis. To test whether or not 
the means of the three groups were all equal we used Tukey’s honestly significant test 
(Tukey’s HSD) for normally distributed data and Kruskal-Wallis H test for non-normally 
distributed data. To compare the means between two unrelated groups (Capsule group vs 
salt group at baseline) we used independent-sample t tests for normally distributed data 
and Mann-Whitney U test for non-normally distributed data. For comparison of related 
samples (baseline vs 26 weeks), we used paired-samples t tests for normally distributed 
data and Wilcoxon Signed-Rank Test for non-normally distributed data. To test time by 
treatment effect we used mixed effect design. 
Pearson’s correlation coefficient or Spearman’s rho were used to examine 
relations between variables, particularly between iodine status and VIP of infants. 
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Multiple regression analyses were used for predicting VIP tests. All variables were 
checked for collinearity using variance inflation rate (VIF) and the variables that met the 
criteria (VIF ≤ 4) were entered into the models. All of the biomarkers analyzed and 
infants anthropometric indices were entered into the models.  Logistic regression was 
used to measure the relation between categorical dependent variables and one or more 
independent variables. Chi-square test of independence of categorical variable was used 
to test whether the effect of one variable depends on the value of another variable. 
Ordered Logistic Regression was used to test significant difference between groups in 
ordinal variable (goiter rate). 
Results 
The baseline characteristics of study participants are presented in Table 1. Neither 
mothers nor infants were significantly different between groups at baseline. The median 
maternal TSH, T4, T3 and Tg were all within the normal range. For both groups combined 
at baseline, the median BMIC was 154 (42, 252) µg/L, median maternal UIC was 107 
(71, 161) µg/L and median infant UIC was 218 (108, 356) µg/L. Of the women, 23% had 
palpable goiter and 52% had visible goiter. 
The median mothers’ age was 22 (20, 25) years, mean body mass index (BMI) 
was 21.5 (2.3) and mid-upper-circumference (MUAC) was 23.3 (1.7) cm. The median 
infants’ age was 5 (3, 7) days. There were 50 (49.9%) male and 51 (50.5%) female 
infants participating in the study. Infants did not differ in any of the anthropometric 
indices. 
As shown in Table 2, the median maternal TSH and T3 significantly decreased at 
26 weeks in both groups. The median maternal T4 decreased in both groups but the 
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decrease was significant only in the I-salt group (p < 0.001). The median maternal Tg did 
not show any significant change. Except T4 (p = 0.014), none of the biomarkers have 
shown treatment by time interaction (data not shown). 
The proportion of mothers with subclinical hypothyroidism significantly 
decreased at 26 weeks compared to baseline in both groups. The incidence of 
hypothyroxinemia in mothers significantly increased in the salt group (p = 0.004). The 
median UIC of mothers and their infants was not significantly different at 26 weeks 
compared to baseline. Breast milk iodine concentration decreased at 26 weeks in the 
capsule group but not in the I-salt group. The median UIC in infants did not show 
significant changes at 26 weeks. 
As shown in Table 3, the median maternal TSH at 26 weeks indicated that 
maternal TSH in the capsule group was significantly higher than in the control group (p = 
0.05). Maternal T4 was significantly higher in the capsule group than in the I-salt group 
(p = 0.002) and T3 was significantly higher in the I-salt group than in the control group (p 
= 0.015). However, the median maternal Tg, BMIC and UIC were not different among 
groups. 
 Prevalence of goiter in mothers was significantly higher in the control group 
followed by mothers in the salt and capsule groups (p < 0.001). As shown in Figure 2, 
percentage of goiter was significantly decreased following iodine supplementation (p < 
0.001). Goiter rate decreased from 76% at baseline to 30% at 26 weeks in the capsule 
group and from 74% at baseline to 43% at 26 weeks in the salt group. From the mothers 
who were recruited at 26 weeks after delivery to serve as control, 92% had goiter. 




Infants’ TSH and T4 were within the normal range in all of the groups and infants’ 
TSH levels were not significantly different between groups (Table 3). However unlike 
mothers, infants T4 was significantly different in all three groups; T4 values were lowest 
in the capsule group, highest in the control group and T4 in salt group was in middle (p < 
0.0001). Among the infants 2% in the capsule, 8% in the salt, 10% in the control groups 
had subclinical hypothyroidism. None of the infants in any group had overt 
hypothyroidism or hypothyroxinemia. Incidence of subclinical hyperthyroidism was high 
in all groups but there was no significant difference between the groups (p = 0.098).  
Infants in the three groups did not differ in WAZ, WLZ, LAZ or in HCAZ scores. 
The mean of these anthropometric indices shows that infants in all groups were above the 
cutoff level set for nutritional insult (≤ -2 Z score).  
In the visual information processing tests infants were significantly different 
between groups in total novelty quotient but not in the other variables. A novelty quotient 
> 0.55 indicates the infants remember the familiar face and anything below 0.55 means 
they did not remember. Based on this classification, 26% of the infants in the capsule, 
51% in the salt and 47% in the control groups remembered the familiar face.     
Table 4 shows significant predictors of the VIP tests using stepwise multiple 
linear regression analysis. Accordingly, in the two groups (capsule and I-salt groups) 
infants one unit increase in UIC/Cre at 26 weeks increased total shift by 0.24 units, 
maternal T4 at baseline increased total shift by 0.23 units and maternal T3 at 26 weeks 
decreased total shift by 0.21 units. About 12% of the variation in total shift was explained 
by the model. Maternal T3 at baseline was associated with a 0.26 unit increase in average 
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longest look and Tg at baseline was associated with a 0.24 unit decrease in average 
longest look and 10.4% of the variation was explained by the model. Similarly, maternal 
T3 at baseline was associated with a 0.24 unit increase in longest look and Tg at baseline 
was associated with a 0.25 unit decrease in longest look and 10% of the variation was 
explained by the model. In the three groups at 26 weeks average look was predicted by 
maternal T3 (β = 0.215, p = 0.011) and TSH (β = 0.227, p = 0.008) at 26 weeks (Data not 
shown). 
In the two supplemented groups, sex was significantly associated with total 
novelty quotient (X2 = 4.54, p = 0.033) and number of looks (X2 = 6.6, p = 0.011) and 
males performed better than females. When the control group was also considered, sex 
was again associated with total novelty quotient (X2 = 4.08, p = 0.028) and similarly 
males performed better than females (Data not shown). 
A logistic regression analysis was used to predict total novelty quotient using 
infants’ sex, WAZ score at baseline, LAZ score at 26 weeks, maternal T3, TSH and T4 at 
26 weeks as predictors. These predictors were selected based on significant correlation. 
Hence comparing to infants of mothers with hypothyroidism (T3 < 0.8 ng/mL), infants of 
mothers with hyperthyroidism (T3 >1.9 ng/mL) were 93% less likely to score novelty 
preference above 55% and females were 65% less likely to score novelty preference 
above 55% compared to male infants (Table 5). The reliability correlation for the longest 
look was 0.78. The correlation for looks during the novelty preference phase was very 
low and varied highly between the left (r = -0.02) and right (r = 0.50) stimulus positions 





We examined the effect of iodine supplementation on thyroid hormone function, 
thyroglobulin, goiter, UIC and BMIC of lactating women and thyroid hormones, UIC and 
visual information processing in infants at age 26 weeks. Mothers in the two 
supplemented groups (capsule and I-salt) were not significantly different in any of the 
biomarkers and other baseline characteristics. Likewise, infants were not different in any 
of the measurements.  
Maternal iodine supplement did not show any effect on infants’ anthropometric 
measurements between groups. In the two treatment groups the mean change in LAZ was 
0.61 (1.08), in WAZ was 0.01 (1.22), and in HCAZ was 0.2 (1.16). The two groups did 
not differ in any of these anthropometric indices. However, 22% of the infants showed 
growth decline at the end of six months (Data not shown). 
Our study population was known to have severe iodine deficiency for decades. 
This was confirmed with repeated studies in different population groups at different times 
20-22,29. However recently, Ethiopia has been categorized as a moderate iodine deficient 
country 30,31. This current study was conducted in 2013, following the implementation of 
salt iodization program in 2012. Perhaps as the result of this, our study population 
showed higher UIC and BMIC than previous studies. The median UIC within one week 
after delivery of all lactating women was 107 (71, 161) µg/L and their infants was 218 
(108, 356) µg/L and the median BMIC was 154 (43, 252) µg/L. This indicates the study 
population was iodine sufficient 32.  
Following 26 weeks of iodine supplementation, plasma TSH in lactating women 
significantly decreased by 54% in the capsule group and by 42% in the I-salt group 
compared to baseline. However, the improvement in TSH was not significantly different 
108 
 
between the mothers who received daily iodine capsule and weekly iodized salt for 26 
weeks. A significant decrease in the proportion of women with subclinical 
hypothyroidism was observed in both groups. Consistent with this, Santiago and 
colleagues reported there was no significant difference in maternal TSH between 
pregnant women who were supplemented with iodized salt and those who were 
supplemented with either 200 µg iodide per day or 300 µg iodide per day 10. Although we 
do not have baseline data for the control group, lactating women recruited at 26 weeks 
after delivery had unexpectedly lower TSH compared to women in the capsule group at 
26 weeks. A study compared control group to women received 300 µg potassium iodide 
during pregnancy and lactation reported that plasma T4 and T3 were significantly higher 
and TSH was significantly lower in the control group than in the counterparts 33.  
Infants’ TSH at the age of 26 weeks was significantly lower and T4 was 
significantly higher than their mothers (p < 0.001 in both). This could be due to the fact 
that the majority of breast feeding mothers iodine intake is excreted into the breast milk 
which provides enough iodine to the infant 5. All of the infants in the current study had 
normal T4 and TSH levels except for 10 infants who had TSH above the cutoff for their 
age. Nonetheless, a high proportion of infants were observed to have subclinical 
hyperthyroidism which indicates a low level of TSH and normal values of T4 and T3 34.  
The effect of iodine supplement in improving thyroid hormone markers does not 
seem consistent in this study. Maternal TSH and T3 decreased significantly following 
iodine supplementation but the change in Tg wasn’t significant. Maternal T4 decreased in 
both groups with a significant decrease in the I-salt group which resulted in a significant 
increase in the proportion of women with hypothyroxinemia. However, in a double-blind, 
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randomized, controlled trial conducted in Morocco, a single capsule of 400 mg of iodine 
as iodized oil given to the breast-feeding mother or a single oral supplement of 100 mg of 
iodine given to her newborn baby did not produce any significant change in maternal and 
infant TSH or T4 at 3 months, 6 months or 9 months after supplementation 35. Such 
inconsistent thyroid hormone response to iodine supplement was also reported in other 
studies 33,36. Pregnant women showed no change or increase in maternal TSH following 
iodine supplement of 50 µg daily, 200 µg daily or 300 µg daily for six months 10,37,38. In 
two other randomized controlled trials, maternal free T4 concentration decreased in both 
controls and treated groups and no difference was observed between groups 39,40. 
However, a longitudinal study showed TSH was negatively correlated with urinary iodine 
excretion in a moderately iodine deficient population 41. 
Thyroid hormone response to iodine supplement may depend on level of 
deficiency and age group. In a recently published review on biomarkers of iodine, it was 
suggested that T4 and T3 are sensitive markers in areas of severe iodine deficiency and 
TSH was considered as a sensitive marker in newborns 31. Thyroglobulin has been 
recommended as a more sensitive indicator than TSH and T4 in iodine deficient and 
excess areas in children, because thyroglobulin is synthesized only in the thyroid 31,42. 
Another group commented that goiter rate, Tg and TSH are good markers to assess iodine 
status in a population but thyroid hormones are fairly imprecise to detect iodine 
deficiency 43. However unlike children, no cutoff point for median Tg for adults has been 
set related to iodine status 42. Serum Tg was correlated with severity of iodine deficiency 
assessed by urinary iodine 31. In the current study Tg positively correlated with T4 (r = 
0.203, p = 0.043) and negatively correlated with TSH (r = -0.261, p = 0.009) but not with 
110 
 
UIC. Maternal T3 negatively correlated with TSH (r = -0.366, p = 0.000) and positively 
correlated with T4 (r = 0.366, p = 0.000). When thyroid markers were categorized to 
examine association with goiter rate, TSH was the only variable that showed significant 
association with goiter (p = 0.016) (Data not shown). 
Maternal goiter significantly decreased in both capsule and I-salt groups at six 
months. As previously mentioned, maternal iodine supplementation for 26 weeks did not 
show any significant difference in T4, T3, TSH and Tg compared to the control group. 
However, goiter rate was significantly lower in the supplemented groups compared to the 
control group. In goitrous children age 6 to 12 years in CÔte d’Ivoire, a 200 mg iodine 
supplement produced a significant and continuous decrease in thyroid gland volume over 
30 weeks. However, similar to our results there was no significant change in serum T4.  
But TSH decreased significantly in the CÔte d’Ivoire study 44. In contrast, in a severely 
iodine deficient area in Senegal 480 mg of iodine given as iodized oil to adults 
significantly increased T4 and decreased rate of goiter, T3 and TSH 45. 
The effect of iodine supplement on maternal thyroid disorders and in children’s 
neurocognitive development in severely iodine deficient areas is well established 46. It is 
unclear however, whether iodine supplement to pregnant women in areas of mild-to-
moderate iodine deficiency affects cognitive function of the offspring 6,47. Children of 
pregnant women who had received iodine supplement from their first trimester compared 
with those who did not receive supplement showed no difference in mental development 
index measured by Bayley Scales of infant development at the age of two years 33. In 
another study in mildly iodine deficient and iodine sufficient area in Spain, consumption 
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of 150 µg/day of iodine supplement by pregnant women did not improve infant 
neuropsychological development at one year of age 48.  
In the present study, infants whose mothers received iodine supplement for 26 
weeks starting within one week after delivery, were not different from the control group 
in most of the visual information processing measures. However, infants in the control 
and I-salt groups were significantly better in novelty quotient (NQ) than infants in the 
capsule group. In total (all three groups together) the mean NQ was 0.52 (0.19) which is 
higher than the mean NQ reported by Kennedy and colleagues 49.  
The look duration or the length of the longest look during the familiarization 
phase (habituation phase) as a measure for attention and processing speed were not 
significantly different between groups. The mean of the longest look duration in both 
groups was 21.1 (18.0). Shorter fixation indicates better attention and faster processing 
speed and predicts later childhood IQ 15,27. In the current study more than 70% of the 
infants in both groups were below the mean with 26% below 10. The average look 
duration, which indicates the speed at which recognition of the familiar stimulus is 
achieved 28, was not significantly different between groups. Although there is no 
established standard for number of looks a child would make during the habituation 
phase or trials to criterion, infants were not significantly different between groups. 
However, the longer it takes an infant to reach the habituation criterion, the longer it is 
taking the infant to learn the face. In this regard 41% of the infants had number of looks 
above the median and 39% had number of looks below the median of 6 (5, 7.7) which 
indicates the later learned the habituation face quickly 50. 
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The visual information processing (VIP) paradigm has been used to assess 
infants’ and children’s information processing speed, recognition memory and attention 
in relation to various factors. Infants whose mothers had high blood DHA concentration 
showed fast information processing speed over the first year as well as less distractibility 
in the second year 51. A study conducted in Ethiopian infants showed that growth was 
associated with development of VIP 49. On the other hand increased prenatal alcohol 
exposure was correlated with longer look, indicating a slower information processing 52. 
Similarly, exposure to toxic substances during pregnancy resulted in poorer recognition 
memory during the first year of the child 53.  
In the present study we have checked for any association between VIP and 
thyroid hormones, thyroglobulin, UIC and children’s anthropometry but no association 
was confirmed.  Nonetheless, infants of the mothers who had hypothyroidism 
remembered the familiar face better than infants of the mothers who had 
hyperthyroidism. Moreover, male infants remembered the familiar face and learned faster 
than female infants. Not much evidence is available regarding iodine intake on infants’ 
cognition performance by sex. However, one study done in 1982 in school children from 
an area of endemic goiter reported that girls showed better cognition improvement as a 
result of iodine supplement than boys 54. Another study from iodine sufficient and mildly 
iodine deficient area reported similar results 11. 
In our multiple regression analyses infant UIC/Cre at 26 weeks and maternal T4 at 
baseline were positive predictors and maternal T3 at 26 weeks was a negative predictor of 
total shift. For average longest look and longest look, both variables that indicate speed of 
processing, maternal T3 at baseline was a positive predictor and maternal Tg at baseline 
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was a negative predictor. None of the infants UIC, T4, TSH or anthropometric measures 
predicted any of the VIP measures. We performed reliability checks for longest look and 
novelty preference. The correlation for longest look was 0.78. However, correlations for 
novelty preference were unacceptably low. This poor reliability was likely due to the fact 
that the stimuli were presented on a single laptop screen, which made it difficult to tell on 
the recorded video whether the child was looking at one of the pictures or away from the 
pictures. For the future this problem could be solved by using two laptops screens that 
can be placed farther apart. 
In conclusion, although the study population had a long history of iodine 
deficiency, the present study showed a median UIC that indicated iodine sufficiency. 
Hence, consistent with other studies 48 maternal iodine supplementation may not show an 
effect in an iodine sufficient population. Moreover, all of the biomarkers measured in this 
study may not respond to iodine supplement in the time of iodine sufficiency. Due to this 
reason, the VIP test did not show any significant change between groups. Except for TSH 
none of the biomarkers showed improvement with supplementation in this study. 
However, the rate of goiter decreased significantly in both supplemented groups and the 
difference with the control group was remarkably high. The only marker that showed 
association with goiter was TSH. The association observed between VIP tests and 
infants’ sex may also require further investigation. 
Findings from this study showed that perhaps, the comments given on the 
sensitivity of different thyroid function markers in different population groups might 
need further investigation. Moreover, this study confirmed that iodized salt showed 
similar effect as iodine capsule supplement if it is adequately iodized and carefully 
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monitored. Results from the present study should be evaluated with caution because data 
were collected immediately after salt iodization program was launched in Ethiopia. 
Therefore, it is too early to comment on the iodine status of the population. Large scale 
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Capsule group                                           I-salt group
Fig. 2. Prevalence of goiter in women at baseline and 26 weeks in the capsule vs 




















Capsule group Isalt group Control group
No goiter (%) 70 57 8
Palpable goiter (%) 30 41 33














Fig.3. Prevalence of goiter of women at 26 weeks in all of the three groups (n = 152)
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Table 1. Socio-demographic and clinical characteristics of mother-infant dyads at    
               baseline (n = 101)  
 Capsule group (n = 50) I-salt group (n = 51) p - value 
Mothers Mean (SD), median 
(IQR) or f (%) 
Mean (SD), median 
(IQR) or f (%) 
 
- Age (years) 23 (20, 27) 21 (20, 25) 0.14 
- MUAC (cm) 23.2 (1.8) 23.3 (1.7) 0.62 
- BMI (kg/m2) 21.2 (2.5) 21.8 (2.0) 0.15 
- Gravidity 2 (1.75, 4) 2 (1, 5) 0.41 
- Parity 2 (1, 4) 2 (1, 4) 0.38 
- School years 2 (2, 3) 2 (1, 3) 0.42 
- T3 (ng/mL) 1.3 (1.0, 1.7) 1.4 (1.2, 1.7) 0.052 
- T4 (µg/dL) 7.0 (5.9, 8.1) 6.8 (5.4, 8.0) 0.57 
- Tg (ng/mL) 4.2 (1.4, 10) 4.5 (2.3, 11.9) 0.25 
- TSH (µIU/mL) 2.6 (1.1, 4.4) 1.9 (0.8, 3.2) 0.11 
- Goiter    
       - Grade 0 12 (24%) 13 (26%) 0.96 
       - Grade 1 11 (22%) 12 (23%)  
       - Grade 2 27 (54%) 26 (51%)  
- UIC (µg/L) 136.3 (76, 173) 95 (64, 142) 0.091 
- BMIC (µg/L) 149 (46, 266) 157 (29, 243) 0.97 
- I/Cre (µg/g) 213.6 (142, 292) 203.3 (139, 268) 0.99 
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 Capsule group (n = 50) I-salt group (n = 51) p - value 
Infants Mean (SD), median 
(IQR) or f (%) 
Mean (SD), median 
(IQR) or f (%) 
 
- Age (days) 5 (3, 7) 6 (5, 8) 0.05 
- UIC (µg/L) 234 (121, 379) 193 (107, 331) 0.39 
- I/Cre (µg/g) 2097 (1001, 3957) 2025 (1397, 3811) 0.94 
Data are median, mean and percentage. Continuous data were analyzed using T-Test 
and Mann-Whitney U test, categorical variable was analyzed using Chi-square test and 
ordinal variable was analyzed using Ordered Logistic Regression. Normality was 
checked using Kolmogorov-Smirnov. UIC = urinary iodine concentration, BMIC = 
breast milk iodine concentration, I/Cre = iodine to creatinine ratio, T3 = 
triiodothyronine, T4 = Throxine, Tg = thyroglobulin, TSH = thyroid stimulating 












Table 2. BMIC, UIC and thyroid hormone markers of mothers and UIC of infants at 
              baseline and at 26 weeks in subjects who received iodine capsule vs iodized salt  
 Baseline 26 weeks p- value 
Mothers    
TSH (µIU/mL)    
- Capsule group 2.6 (1.1, 4.4) 1.2 (0.9, 2.4) 0.009 
- I-salt group 1.9 (0.8, 3.2) 1.1 (0.7, 1.8) 0.006 
T4 (µg/dL)    
- Capsule group 7.0 (5.9, 8.1) 6.7 (5.5, 8.0) 0.450 
- I-salt group 6.8 (5.4, 8.0) 5.4 (4.8, 6.9) < 0.001 
Subclinical hypothyroidism    
- Capsule group 32% (16/50) 2% (1/50) 0.001 
- I-salt group 14% (7/51) 0% 0.016 
Hypothyroxinemia    
- Capsule group 8% (4/50) 16% (8/50) 0.180 
- I-salt group 8% (4/51) 31% (16/51) 0.004 
T3 (ng/mL)    
- Capsule group 1.3 (0.5) 1.1 (0.4) 0.019 
- I-salt group 1.5 (0.4) 1.2 (0.4) 0.002 
Tg (ng/mL)    
- Capsule group 4.2 (1.4, 10.0) 4.2 (1.8, 9.0) 0.495 
- I-salt group 4.5 (2.3, 11.9) 4.2 (2.1, 8.1) 0.07 
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 Baseline 26 weeks p- value 
Mothers    
UIC (µg/L)    
- Capsule group 136 (76, 173) 150 (86, 220) 0.082 
- I-salt group 95 (64, 142) 110 (73, 191) 0.066 
BMIC (µg/L)    
- Capsule group 149 (46, 266) 104 (39, 197) 0.036 
- I-salt group 157 (28, 243) 111 (34, 202) 0.127 
Infants     
UIC (µg/L)    
- Capsule group 234 (121, 379) 254 (130, 400) 0.340 
- I-salt group 193 (107, 331) 195 (108, 352) 0.967 
Data are median, mean and percentages. Continuous data are analyzed using paired samples T-
test or Wilcoxon, proportions (percentages) were analyzed using McNemar. Subclinical 
hypothyroidism defined as increased TSH and normal T4 (TSH > 3.7 µIU/mL and normal T4) 













Table 3. Thyroid hormone markers, UIC and BMIC of mothers, and anthropometry and   
               visual information processing tests of infants at 26 weeks (n = 152) 
 Capsule group (50) I-salt group (51) Control group (51) p - value 
Mothers     
TSH (µIU/mL) 1.2 (0.9, 2.4)a 1.1 (0.7, 1.8)ab 0.8 (0.5, 1.7)b 0.05 
T4 (µg/dL) 6.7 (5.5, 8)a 5.4 (4.8, 6.9)b 6.0 (5.1, 7.4)ab 0.002 
Subclinical hypothyroidism 2% (1/50) 0 2% (1/51) 0.599 
Overt hypothyroidism 2% (1/50) 2% (1/50) 0 0.605 
Hypothyroxinemia 16% (8/51) 31% (16/51) 22% (11/51) 0.203 
Subclinical hyperthyroidism 0 2% (1/51) 2% (1/51) 0.241 
T3 (ng/mL) 1.14 (0.4)ab 1.25 (0.4)a 1.03 (0.4)b 0.015 
Tg (ng/mL) 4.2 (1.8, 9) 4.2 (2, 8) 3.8 (2, 8) 0.89 
UIC (µg/L) 174 (85, 220) 110 (73, 191) 157 (102, 243) 0.31 
BMIC (µg/L) 104 (39, 197) 111 (34, 202) 114 (43, 172) 0.99 
Goiter     
       - Grade 0 35 (70%) 29 (57%) 4 (8%) < 0.001 
       - Grade 1 15 (30%) 21 (41%) 17 (33%)  
       - Grade 2 0 1 (2%) 30 (59%)  
Infants     
TSH (µIU/mL) 0.56 (0.1, 1.6) 0.5 (0.1, 1.3) 0.1 (0.1, 1.3) 0.96 
T4 (µg/dL) 10.8 (8.7, 13.6)c 13.9 (10.6, 17.6)b 19.6 (16.4, 25.9)a < 0.001 
UIC (µg/L) 253 (130, 400) 195 (108, 351) 200 (113, 329) 0.49 
Subclinical hypothyroidism 2% (1/50) 8% (4/51) 10% (5/51) 0.259 
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Infants Capsule group (50) I-salt group (51) Control group (51) p - value 
Subclinical hyperthyroidism 30% (15/50) 39% (20/51) 51% (26/51) 0.098 
WAZ score -0.35 (1.3) -0.4 (1.1) -0.5 (1.3) 0.73 
WLZ score 0.38 (1.1) 0.46 (1.2) 0.13 (1.2) 0.36 
LAZ score -0.8 (1.3) -1.1 (1.1) -0.8 (1.2) 0.57 
HCAZ score (cm) 0.73 (0.24, 1.62) 0.78 (-0.24, 1.60) 0.74 (0.09, 1.63) 0.74 
VIP tests of infants     
Total shift 4 (2, 6) 4 (2, 6) 4 (2, 6) 0.92 
No. of looks 6 (5, 7) 6 (5, 8) 6 (5, 8) 0.34 
Average look 9.6 (5.8) 8.0 (5.2) 8.9 (5.7) 0.38 
Longest look 22.5 (17.8) 19.5 (19.1) 21.3 (17.4) 0.41 
Total novelty quotient (> 
0.55) 
    
       - Yes 13 (26%) 26 (51%) 24 (47%) 0.024 
       -  No 37 (74%) 25 (49%) 27 (53%)  
Data are median, mean and percent. Continuous data were analyzed using Tukey’s HSD post hoc test, 
ordinal data was analyzed using Ordered Logistic Regression and categorical data were analyzed using 
Chi-square test. Subclinical hypothyroidism defined as increased TSH and normal T4 (TSH > 3.7 
µIU/mL and normal T4), overt hypothyroidism defined as increased TSH and low T4 (TSH > 3.7 
µIU/mL and T4 < 5.05 µg/dL), hypothyroxinemia defined as T4 less than age-specific cut-off (T4 < 5.05 
µg/dL) and subclinical hyperthyroidism is defined as increased TSH (TSH > 3.7 µIU/mL and normal T3 
and T4 34,35. 
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Table 4. Multiple regression predicting VIP tests using stepwise criteria (n = 101) 
Dependent variables Predictors Beta p  
Total shift Infants UIC/Cre at 26 weeks 0.24 0.02 
 Maternal T3 at 26 weeks -0.21 0.043 
 Maternal T4 at baseline 0.226 0.029 
 Adjusted R  square = 0.12 
Average looks Maternal T3 at baseline 0.262 0.008 
 Maternal Tg at baseline -0.24 0.015 
 Adjusted R square = 0.104 
Longest look Maternal Tg at baseline -0.249 0.012 
 Maternal T3 at baseline 0.238 0.016 
















Table 5. Maternal thyroid hormones, infants nutritional status and gender as associates of  
              infants  total novelty quotient (n = 152) 
 Total Novelty Quotient 
> 0.55 
OR (95% CI) p 
Variables Yes No   
Child sex     
- Male 24 26 1.00  
- Female 14 37 0.350 (0.139, 0.907) 0.030 
Maternal T3 at 26 wks     
- < 0.8 ng/mL 9 7 1.00  
- 0.8 – 1.9 ng/mL 25 54 0.287 (0.022, 3.716) 0.339 
- > 1.9 ng/mL 4 1 0.076 (0.007, 0.799) 0.032 
Maternal TSH at 26 wks     
- < 3.7 µIU/mL 37 61 1.00  
- > 3.7 µIU/mL 1 2 0.613 (0.045, 8.350) 0.714 
Maternal T4 at 26 wks     
- < 5.05 µg/dL 10 14 1.00  
- > 5.05 µg/dL 28 48 1.185 (0.393, 3.581) 0.763 
WAZ score of infants at 
baseline 
    
- < -1 Z score 13 11 1.00  
- > -1 Z score 25 52 0.390 (0.118, 1.180) 0.093 
LAZ score of infants at 26 
wks 
    
- < -1 Z score 23 25 1.00  







Title: High variability of iodine in salt and of urinary iodine concentrations (UIC) from 
rural households in Sidama zone, southern Ethiopia  
Abstract 
Background: Iodine is a chemical element essential for the synthesis of thyroid 
hormones. Iodine deficiency is one of the most common nutritional problems in the 
world. The study population had a long history of severe iodine deficiency.  
Objective: To assess urinary iodine concentration, rate of goiter in mothers and school-
age children and household salt iodine concentration in a small sample of households 10 
months after launch of the national salt iodization program.  
Design: Cross-sectional study on a randomly selected sample of women and school 
children. Goiter was assessed by palpation. Concentrations of iodine in salt, urine and 
water were analyzed by inductively coupled plasma mass spectrometery (ICP-MS). 
Setting: Sidama zone, southern Ethiopia. 
Subjects: Mothers and school children age 5 to 16 years. 
Results: The study included 193 mothers and 76 children. The median UIC was 143 (84, 
202) µg/L in the mothers and 187 (102, 278) µg/L in the children. Mother’s UIC ranged 
from 16.7 to 767.2 µg/L and children’s UIC ranged from 18.7 to 738.7 µg/L. Rate of 
goiter was high with 79% in the mothers and 71% in the children. The median salt iodine 
concentration (SIC) was 8 (4.3, 13.4) ppm (mg/kg) with a range from 0 to 42 ppm. 
Despite the launch of salt iodization program in Ethiopia, 94% of the study participants
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said they did not use iodized salt and 88% did not know the benefits of iodized salt. Of 
the 24 mothers who reported knowing the benefits of iodized salt, 23 said it prevents 
goiter but none mentioned cognitive effects. Iodine content of their drinking water was 
below the detection limit of 1 µg/L. 
Conclusions: The only apparent source of iodine for this population was iodized salt; 
however, the salt contained minimal but variable amounts of iodine. The high variability 





Iodine is a chemical element found in trace amounts in the human body and is 
primarily obtained through the diet 1. Iodine is essential for the synthesis of thyroid 
hormones which regulate the metabolic processes of most cells and play important roles 
in human growth and development 2.  
Iodine deficiency is one of the most common nutritional problems of the world. 
Globally, it is estimated that 2 billion people, most of them in developing countries, 
suffer inadequate intakes of iodine 3. Due to its multiple effects on human health, iodine 
deficiency is referred to as iodine deficiency disorders (IDDs) 4. Enormous progress 
towards eliminating iodine deficiency has been made, however iodine deficiency is 
reappearing even in developed countries 5. 
In Ethiopia the goiter rate among 15 to 49 years old women was 35.8% and in 
school age children was 40% in a survey conducted in 2005. In the southern region of the 
country, of 1702 women examined for goiter, 43.2% had palpable and 17.7% had visible 
goiter, which is a total goiter rate of 60.9%. In school children in the same region, the 
prevalence of goiter was 56.2%. These data show that Ethiopia, particularly the southern 
region, was severely affected by iodine deficiency 6,7. However, recently Ethiopia has 
been identified as one of the few African countries where iodine deficiency was a 
moderate problem 5. 
Iodine is widely distributed in the environment as iodide. Iodine found in the soil 
can be washed away by leaching, flooding and erosion, which leaves the soil and 
drinking water depleted of iodine. Plants grown in this soil will be low in iodine content 
and hence animals and humans that rely on these plants will most likely become iodine 
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deficient 8. For people who reside in iodine-deficient areas, the best ways to alleviate 
iodine deficiency are using iodized salt and diversifying local food with foods from 
iodine-sufficient areas. Iodine containing compounds such as fertilizers, livestock feed, 
and compounds used in irrigation and  milk processing can increase iodine content in 
food as well as dairy products 9.    
A review in 30 developing countries showed that urinary iodine concentration 
(UIC) was significantly correlated with household iodized salt availability 10. In a 
prospective study in Denmark 4 years after a mandatory salt iodization program (13 ppm 
iodine) a lower median thyroid volume was observed in women age 18 to 65 years old. 
And a large relative decline of thyroid volume was observed in younger females from 
places where iodine deficiency was moderate 11. A national survey on iodine deficiency 
was conducted in Tanzania after twelve years of a salt iodization program. The iodine 
status of school children, aged 6 to 18 years, was assessed by goiter rate (n = 140,358) 
and UIC (n = 4523). Total goiter rate significantly decreased from 61% in the 1980s to 
12.3% in 2004 and the median UIC was found to be 204 µg/L 12.   
In Ethiopia, the salt iodization program was launched early 2012. Ten months 
after we collected our data for this study in 2013, the Ethiopian Public Health Institute 
reported that the national iodized salt coverage (above 0 ppm) was 95.2% with 42.7% of 
the households having salt with iodine greater than 15 ppm and 23.2% falling within the 
national standard (20 to 40 ppm) 13. However, to the best of our knowledge no study has 
reported the impact of the salt iodization program on urinary iodine and rate of goiter in 
any part of the country following the launch of the salt iodization program. 
136 
 
The purpose of the present study was to assess urinary iodine concentration, rate 
of goiter in mothers and school-age children and household salt iodine concentration in a 
small sample of households 10 months after launch of the national salt iodization 
program. Moreover, knowledge of mothers about IDDs as well as the practices and 
utilization of iodized salt were assessed.  
Materials and methods 
The study was conducted in Sidama zone, southern Ethiopia where iodine 
deficiency was highly prevalent prior to the national salt iodization program 14-16. Sidama 
zone has a variety of climate conditions and its elevation ranges from 500 m to 1500 m 
above sea level. The major staple foods are corn and enset (Enset ventricosum) 17.  
The study participants were recruited from eight kebeles (the smallest 
administrative unit) from randomly selected households which included 40 mothers and 
76 school age children and 153 lactating women recruited for another study.  
Urine samples were collected from mothers and children for analysis of UIC. 
Because 90% of dietary iodine is excreted in the urine, UIC is a commonly used 
biochemical indicator for iodine status 18. Urine samples were collected in a cup from 
each participant and transferred to tightly sealed vials. Water samples from eight 
communal water tap points and from nearby Lake Awassa were collected for iodine 
analysis. A 10 g salt sample was collected from each household for iodine content 
analysis.  
The mother’s knowledge, attitude and practice about iodized salt, iodine 
deficiency, goiter and other related factors were assessed using open-ended questions. 
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Open-ended questions were re-coded for analysis. Socio-demographic data were 
collected using structured interview.  
Laboratory analysis 
Urinary and drinking water iodine concentrations were analyzed by inductively 
coupled plasma mass spectrometery (ICP-MS Elan 9000, Perkin Elmer, Norwalk, CT). 
Salt iodine concentration (SIC) was analyzed with a portable digital electronic iodine 
checker (WYD, UNICEF) and re-analyzed using inductively-coupled-plasma mass 
spectrometry. In measuring SIC using the two methods a reasonably good correlation was 
obtained (r = 0.745, p < 0.001). Total goiter of mothers and children was determined by 
palpation based on the following grades: grade 0, no palpable or visible goiter; grade 1, 
palpable goiter but not visible when neck is in the normal position; grade 2, visible goiter 
when neck is in the normal position 19. 
Statistical analysis 
Data were analyzed using SPSS statistics for Windows v. 20.0 (Armonk, NY: 












Demographic and socio-economic characteristics of study participants are 
presented in Table 1. The mean age of the mothers was 25.6 (8.1) and the children was 
9.6 (4.4) years. The mean household size was 5.6 (2.1) and mean number of children was 
3.2 (1.8). Among the children who participated in this study, 60% were males. Of the 
respondents, 55% had some formal education. Household food insecurity was high in the 
study participants with 14% severely, 24% moderately and 15% mildly food insecure. 
The median UIC of mothers was 143 and of the children was 187 µg/L, which is 
above the cutoff for an iodine deficient area 18 (Table 2). As indicated in Figure 1, UICs 
of both mothers and children were above the cutoff (100 µg/L) for iodine sufficiency. 
Only one mother and one child had UIC below 20 µg/L. Overall 67.5% of the mothers 
and 77% of the children had adequate, more than adequate or excessive iodine intakes.  
However, the rate of goiter was highly prevalent in both mothers and children. 
Most (76%) of the women and 71% of the children had either palpable or visible goiter. 
The high rate of goiter indicates goiter was far above what would be called a public 
health problem 18 (Table 2).  
A markedly high variation was observed in SIC. Nearly 79% of the salt samples 
contained low iodine concentration, below the minimum requirement (15 ppm) for 
adequately iodized salt (Table 2). Only 21% of the salt samples analyzed met the 
requirement for adequate iodized salt (15 – 40 ppm). Overall the SIC ranged between 0 
ppm to 42 ppm. We also analyzed water iodine concentration from eight communal tap 
water points and from the lake but none of the water samples contained iodine above the 
detection limit of 1 µg/L (data not shown). 
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Despite the launching of the salt iodization program in Ethiopia, nearly 94% of 
the women interviewed did not know whether or not the salt they were using was iodized. 
Except one woman, all of the women said they use rock (non-iodized) salt for cooking 
and only 24 (12%) women knew the benefits of iodized salt. Among those, 23 women 
said iodized salt prevents goiter (Table 3). Of the 39 (20%) women who said they know 
the causes of goiter. Only 10 of the respondents related goiter to lack of iodine in salt or 
iodine itself  (Table 3).  
As indicated in table 4, the majority of the women add salt to food near the end of 
cooking and 38% said they cook the salt together with the food. They add variable 
amounts of salt to food and the amount of salt was estimated by teaspoon (tsp). Most of 













The best way to alleviate iodine deficiency disorders is to implement universal 
salt iodization 3. The results of the present study showed a significant improvement in 
urinary iodine and salt iodine concentration following the salt iodization program 
launched in 2012 in Ethiopia. However, a high prevalence of goiter with 76% in mothers 
and 71% in children remained a serious problem 18.  
Compared to previous studies the pattern of UIC distribution in both mothers and 
children is shifting towards iodine adequacy. In consecutive years from 2007 to 2010 in 
similar study areas, the proportion of study participants with UIC below 100 µg/L (an 
indicator for iodine inadequacy) was nearly 100%. In 2007, 99% of the children involved 
in the study had UIC below 20 µg/L 20. In 2009, 89% of the pregnant women had UIC 
below 50 µg/L with 60% below 20 µg/L 15. Similarly in 2010, the proportion of women 
with UIC below 100 µg/L was 96% 16. In the present study the proportion of mothers and 
children with UIC below 20 µg/L was almost zero. Except for 8.5% of mothers and 7% 
of children, the rest had UIC above 100 µg/L. However, the high variability observed in 
UIC is of a great concern. Mother’s UIC ranged from 16.7 to 767.2 µg/L and children’s 
UIC ranged from 18.7 to 738.7 µg/L.  
The study population has poor dietary sources of iodine 16. The iodine 
concentration of their drinking water was also extremely low. Hence the high variability 
in UIC could be explained from the high variability observed in SIC. Salt iodine 
concentration ranged from 0 ppm to 42 ppm. The variability in SIC is again a great 
concern because it is highly likely that one can get non-iodized salt one day and 
excessively iodized salt another day because the mothers normally buy small amounts of 
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salt that they could use for one to three days. The ultimate goal of universal salt 
iodization program or salt iodization program is to alleviate iodine deficiency but if it is 
not seriously monitored, excessive iodine intake could also be of great concern 5. In 
Ethiopia is iodized manually using Knapsack sprayers and small scale iodization 
machines which make it difficult to homogeneously iodized salt 13.  
Nonetheless, although early awareness is necessary for a quick improvement and 
better product, it could be too early to comment on the Ethiopia salt iodization program at 
this time. In Saudi Arabia, 20 years after a universal salt iodization program was 
implemented SIC showed variation from  0 to 112 ppm 21. A drastic decrease over time in 
the iodine content of salt was observed in Cambodia despite a mandatory salt iodization 
program. The median iodine content of salt dropped from 22 ppm in 2011 to 0 ppm in 
2014. It was assumed that this drastic drop in salt iodine content could be due to 
infiltration of non-iodized salt from the production site to the market and/or due to 
inappropriately packaging of iodized salt 22. Long term experience from different 
countries showed that salt iodization programs can only be effective and sustainable with 
strong monitoring strategies and commitment from government, donors, producers, 
distributors and consumers 23. 
Maintaining the sustainability of a salt iodization program requires its own 
multidimensional commitment, and retaining the iodine in the salt in turn requires careful 
storage, handling and proper utilization methods. Iodine is a volatile trace mineral and 
hence it can easily be lost from improper storage, handling and cooking process. It was 
estimated that 20% of the iodine will be lost during the cooking process 18. A study in 
Wukro, Northern Ethiopia, confirmed that 57% of the salt iodine content that was 
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available at the production level was lost by the time  it reached the household 24. The 
stability of iodine in salt can be affected by impurities and alkalinity or acidity and 
moisture content of salt, heat, light and humidity 25. In the present study except for two 
mothers who added salt to food after cooking, the rest cooked the salt with food.  Most 
stored the salt in containers likely to contain moisture which could cause iodine loss. 
Only five mothers purchased salt from retail shops; the remainder of the mothers (97%) 
purchased salt from the open market. From our observation the salt in the open market is 
highly exposed to impurities, warm temperature and humidity (Data not shown). 
Since the launch of salt iodization program in Ethiopia, it was assumed that all the 
salt in the market was iodized. However, of the participants, 94% said they did not use 
iodized salt and 88% did not know the benefits of iodized salt. Of the 24 mothers who 
reported knowing the benefits of iodized salt, 23 said it prevents goiter but none 
mentioned cognitive effects. The mothers suggested causes of goiter to be drinking dirty 
water, drinking tap water, drinking rain water, but only 10 mothers said lack of iodine or 
lack of iodized salt. Although prevalence of goiter is high and visible in the community, 
knowledge of causes and prevention of iodine deficiency disorders (IDD) is minimal.   
Because the majority of the mothers said they did not use iodized salt does not 
indicate the salt was not iodized, but that they do not even know the difference between 
iodized and non-iodized salt. From our observation we have understood that the iodized 
salt was packed in 50 kg bags. But rural people purchase small amounts of salt enough 
for one to three days. Therefore, there is no way for them to get the information labeled 
in the 50 kg bags.  For effective transfer of information and minimizing the loss as a 
result of poor storage conditions, packaging of iodized salt in small amounts might help.  
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In conclusion the only apparent source of iodine for this population was iodized 
salt; however, the salt contained minimal but variable amounts of iodine.  Lack of iodized 
salt may be further compounded by storage, handling and cooking techniques. Until 
machinery based salt iodization techniques and effective monitoring strategies are 
materialized it is difficult to sustain a good quality salt iodization program. Moreover, 
mechanisms should be devised to control the infiltration of non-iodized salt to the local 
market. In order to enable the community to say ‘No!’ for non-iodized salt it is 
indispensable to create awareness about IDDs and causes, consequences and prevention 
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Figure 1. Urinary iodine concentration of mothers and children 10 months after salt 


















































Fig 1b. UIC of children in 2013
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Table 1. Socio-demographic characteristics of study participants 
 Mean (SD) Percent 
Mothers (n = 193)   
Mothers age (years) 25.6  (8.1)  
Household size 5.7 (2.1)  
Number of children 3.2 (1.8)  
Mothers education (%)   
- No formal education  45 
- Some education  55 
Children (n = 76)   
Children’s age (years)  9.6 (4.4)  
Children’s gender (%)   
- Male  60 













Table 2. Urinary iodine concentration of mothers and children and salt iodine  
              concentration from Sidama zone, southern Ethiopia 
 Median (IQR) Percent 
Maternal UIC (µg/L) 143 (84, 202)  
Maternal goiter   
- No goiter  24 
- Palpable goiter  26 
- Visible goiter  50 
Children’s UIC(µg/L) 187 (102, 278)  
Children’s goiter   
- No goiter  29 
- Palpable goiter  60 
- Visible goiter  11 
Household SIC (ppm) 8 (4.3, 13.4)  
- < 5 ppm  28.6 
- 5 – 9.9 ppm  31.8 
- 10 – 15 ppm  18.2 
- > 15 ppm  21.4 







Table 3. Mother’s knowledge of iodized salt and causes of goiter 
Questions to the women Frequency Percent 
What kind of salt do you use?   
- Rock salt  192 99.5 
- Packed iodized salt 1 0.5 
Do you use iodized salt?   
- Yes 12 6.2 
- No 181 93.8 
Do you know the benefits of 
iodized salt? 
  
- Yes 24 12.4 
- No 169 87.6 
What is the benefit of iodized salt?   
- Prevents goiter 23 95.8 
- Makes one strong 1 4.2 
Do you know the causes of goiter?   
- Yes 39 20.2 
- No 154 79.8 
What are the causes of goiter?   
- Drinking dirty water 14 35.9 
- Lack of iodine in salt 8 20.5 
- Drinking tap water 4 10.3 
- Drinking rain water 4 10.3 

















Questions to the women Frequency Percent 
- Lack of salt 2 5.1 
- Lack of iodine 2 5.1 
- Drinking untreated water 1 2.6 
- Drinking river water 1 2.6 
- Hereditary 1 2.6 
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Table 4. Utilization and handling of salt (n = 193) 
Questions to the women Frequency Percent 
When do you add salt to food when 
cooking? 
  
- Cook together 73 37.8 
- At the end 118 61.2 
- After cooking 2 1 
How much salt (tsp) do you add to each 
food that you cook? 
  
- One 130 67.4 
- Two 59 30.6 
- Three 4 2 
How do you store your salt?   
- In a tight bottle 21 10.9 
- In a water bottle 133 68.9 
- In a plastic bag 38 19.7 
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Annex 1. Table A. Correlation coefficients of maternal thyroid function markers and infants iodine status at baseline  
               and infants VIP tests  








M_Tg 1.00         
M_T3 0.05 1.00        
M_T4 0.09 0.36** 1.00       
M_TSH -0.13 0.08 -0.06 1.00      
C_UIC 0.12 0.29** 0.18 -0.01 1.00     
C_UIC/Cre 0.02 -0.032 0.01 -0.18 0.53** 1.00    
Total shift 0.28** 0.09 0.10 0.07 0.16 0.01 1.00   
Average look -0.20* 0.24* 0.13 0.16 0.05 0.01 -0.11 1.00  
Longest look -0.22* 0.22* 0.14 0.15 0.05 0.02 -0.13 0.96*** 1.00 
 
Note: M_Tg – Maternal thyroglobulin, M_T3 – Maternal triiodothyroinie, M_T4 – Maternal 









Annex 2. Table B. Correlation coefficients of maternal thyroid function markers and infants iodine status at six months 
               and infants VIP tests  
Variables M_Tg M_T3 M_T4 M_TSH C_UIC C_UIC/
Cre 






M_Tg 1.00           
M_T3 0.13 1.00          
M_T4 0.21* 0.37** 1.00         
M_TSH -0.25* -0.37** -0.05 1.00        
C_UIC 0.12 -0.09 0.08 0.01 1.00       
C_UIC/Cre -0.01 -0.09 -0.07 -0.05 0.18 1.00      
C_TSH 0.16 0.05 -0.01 -0.06 0.11 0.01 1.00     
C_T4 0.01 -0.04 -0.06 -0.08 -0.17 0.03 0.25* 1.00    
Total shift 0.04 -0.12 -0.05 -0.03 0.09 0.17 0.01 -0.01 1.00   
Average look -0.17 0.11 0.24* 0.26** -0.04 0.03 0.01 -0.14 -0.11 1.00  
Longest look -0.18 0.12 0.26** 0.25* -0.09 -0.01 -0.08 -0.16 -0.13 0.96*** 1.00 
 
Note: M_Tg – Maternal thyroglobulin, M_T3 – Maternal triiodothyronine, M_T4 – Maternal 
thyroxine, M_TSH – Maternal TSH, C_UIC – Children UIC, C_UIC/Cre – Children UIC/Creatinine, 
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